WO2000008169A1 - Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants - Google Patents
Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants Download PDFInfo
- Publication number
- WO2000008169A1 WO2000008169A1 PCT/EP1999/005467 EP9905467W WO0008169A1 WO 2000008169 A1 WO2000008169 A1 WO 2000008169A1 EP 9905467 W EP9905467 W EP 9905467W WO 0008169 A1 WO0008169 A1 WO 0008169A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- seq
- plants
- doxs
- plant
- dna sequence
- Prior art date
Links
- 108010060155 deoxyxylulose-5-phosphate synthase Proteins 0.000 title claims abstract description 168
- 108091028043 Nucleic acid sequence Proteins 0.000 title claims description 127
- 238000012261 overproduction Methods 0.000 title abstract description 3
- 241000196324 Embryophyta Species 0.000 claims abstract description 261
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 60
- 238000004519 manufacturing process Methods 0.000 claims abstract description 47
- 238000000034 method Methods 0.000 claims abstract description 32
- 230000014509 gene expression Effects 0.000 claims description 109
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 77
- 229930003799 tocopherol Natural products 0.000 claims description 75
- 239000011732 tocopherol Substances 0.000 claims description 75
- 230000001965 increasing effect Effects 0.000 claims description 68
- 235000010384 tocopherol Nutrition 0.000 claims description 54
- 229960001295 tocopherol Drugs 0.000 claims description 54
- 235000021466 carotenoid Nutrition 0.000 claims description 53
- 150000001747 carotenoids Chemical class 0.000 claims description 53
- 229930002875 chlorophyll Natural products 0.000 claims description 45
- 235000019804 chlorophyll Nutrition 0.000 claims description 45
- 235000019168 vitamin K Nutrition 0.000 claims description 39
- 239000011712 vitamin K Substances 0.000 claims description 39
- 229930003448 Vitamin K Natural products 0.000 claims description 38
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 claims description 38
- 150000003721 vitamin K derivatives Chemical class 0.000 claims description 38
- 229940046010 vitamin k Drugs 0.000 claims description 38
- 240000002791 Brassica napus Species 0.000 claims description 37
- 210000004027 cell Anatomy 0.000 claims description 37
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 claims description 29
- 229940106705 chlorophyll Drugs 0.000 claims description 23
- 230000009466 transformation Effects 0.000 claims description 23
- 235000004977 Brassica sinapistrum Nutrition 0.000 claims description 22
- OINNEUNVOZHBOX-XBQSVVNOSA-N Geranylgeranyl diphosphate Natural products [P@](=O)(OP(=O)(O)O)(OC/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)O OINNEUNVOZHBOX-XBQSVVNOSA-N 0.000 claims description 22
- 235000019149 tocopherols Nutrition 0.000 claims description 21
- 230000001131 transforming effect Effects 0.000 claims description 21
- QUEDXNHFTDJVIY-UHFFFAOYSA-N γ-tocopherol Chemical class OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-UHFFFAOYSA-N 0.000 claims description 21
- 206010020649 Hyperkeratosis Diseases 0.000 claims description 18
- 239000001752 chlorophylls and chlorophyllins Substances 0.000 claims description 16
- 235000006008 Brassica napus var napus Nutrition 0.000 claims description 15
- 108090000854 Oxidoreductases Proteins 0.000 claims description 15
- 102000004316 Oxidoreductases Human genes 0.000 claims description 15
- 102000016680 Dioxygenases Human genes 0.000 claims description 11
- 108010028143 Dioxygenases Proteins 0.000 claims description 11
- 238000012360 testing method Methods 0.000 claims description 11
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims description 10
- 239000003112 inhibitor Substances 0.000 claims description 10
- 230000008569 process Effects 0.000 claims description 10
- 210000001938 protoplast Anatomy 0.000 claims description 9
- 235000007319 Avena orientalis Nutrition 0.000 claims description 6
- 244000075850 Avena orientalis Species 0.000 claims description 6
- 235000014698 Brassica juncea var multisecta Nutrition 0.000 claims description 6
- 235000006618 Brassica rapa subsp oleifera Nutrition 0.000 claims description 6
- 235000010469 Glycine max Nutrition 0.000 claims description 6
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 6
- 244000020551 Helianthus annuus Species 0.000 claims description 6
- 240000008042 Zea mays Species 0.000 claims description 6
- 235000002017 Zea mays subsp mays Nutrition 0.000 claims description 6
- 240000005979 Hordeum vulgare Species 0.000 claims description 5
- 235000007340 Hordeum vulgare Nutrition 0.000 claims description 5
- 241000209140 Triticum Species 0.000 claims description 5
- 235000021307 Triticum Nutrition 0.000 claims description 5
- 230000001580 bacterial effect Effects 0.000 claims description 3
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000016383 Zea mays subsp huehuetenangensis Nutrition 0.000 claims description 2
- 235000009973 maize Nutrition 0.000 claims description 2
- 239000002245 particle Substances 0.000 claims description 2
- 244000188595 Brassica sinapistrum Species 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 44
- 241000588724 Escherichia coli Species 0.000 abstract description 19
- 241000219194 Arabidopsis Species 0.000 abstract description 7
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 abstract description 5
- 235000019165 vitamin E Nutrition 0.000 abstract description 4
- 239000011709 vitamin E Substances 0.000 abstract description 4
- 229930003427 Vitamin E Natural products 0.000 abstract description 3
- 229940046009 vitamin E Drugs 0.000 abstract description 3
- 108090000623 proteins and genes Proteins 0.000 description 134
- 239000013598 vector Substances 0.000 description 81
- 239000012634 fragment Substances 0.000 description 76
- 230000009261 transgenic effect Effects 0.000 description 54
- 108090000765 processed proteins & peptides Proteins 0.000 description 51
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 42
- 108091034117 Oligonucleotide Proteins 0.000 description 37
- 239000013612 plasmid Substances 0.000 description 32
- 210000002706 plastid Anatomy 0.000 description 28
- 239000002299 complementary DNA Substances 0.000 description 27
- 230000008488 polyadenylation Effects 0.000 description 27
- 108020004414 DNA Proteins 0.000 description 26
- 244000061176 Nicotiana tabacum Species 0.000 description 26
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 26
- 239000002609 medium Substances 0.000 description 25
- 210000001519 tissue Anatomy 0.000 description 25
- 102000014701 Transketolase Human genes 0.000 description 23
- 108010043652 Transketolase Proteins 0.000 description 23
- 108091026890 Coding region Proteins 0.000 description 21
- 125000003729 nucleotide group Chemical group 0.000 description 18
- 241000701489 Cauliflower mosaic virus Species 0.000 description 17
- 239000002773 nucleotide Substances 0.000 description 17
- 230000005030 transcription termination Effects 0.000 description 17
- 230000000694 effects Effects 0.000 description 16
- 230000002018 overexpression Effects 0.000 description 16
- 230000001105 regulatory effect Effects 0.000 description 16
- 238000006243 chemical reaction Methods 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 14
- 235000011180 diphosphates Nutrition 0.000 description 14
- 210000002472 endoplasmic reticulum Anatomy 0.000 description 14
- 230000006698 induction Effects 0.000 description 14
- 150000007523 nucleic acids Chemical group 0.000 description 14
- 238000012163 sequencing technique Methods 0.000 description 14
- 235000002595 Solanum tuberosum Nutrition 0.000 description 13
- 244000061456 Solanum tuberosum Species 0.000 description 13
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 13
- 210000003763 chloroplast Anatomy 0.000 description 13
- 102000004196 processed proteins & peptides Human genes 0.000 description 13
- 150000003505 terpenes Chemical class 0.000 description 13
- 241000219195 Arabidopsis thaliana Species 0.000 description 12
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 12
- 229940087168 alpha tocopherol Drugs 0.000 description 12
- 102000037865 fusion proteins Human genes 0.000 description 12
- 108020001507 fusion proteins Proteins 0.000 description 12
- IGMNYECMUMZDDF-UHFFFAOYSA-N homogentisic acid Chemical compound OC(=O)CC1=CC(O)=CC=C1O IGMNYECMUMZDDF-UHFFFAOYSA-N 0.000 description 12
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 12
- NUHSROFQTUXZQQ-UHFFFAOYSA-N isopentenyl diphosphate Chemical compound CC(=C)CCO[P@](O)(=O)OP(O)(O)=O NUHSROFQTUXZQQ-UHFFFAOYSA-N 0.000 description 12
- -1 prenyl lipid Chemical class 0.000 description 12
- 229960000984 tocofersolan Drugs 0.000 description 12
- 235000004835 α-tocopherol Nutrition 0.000 description 12
- 239000002076 α-tocopherol Substances 0.000 description 12
- OINNEUNVOZHBOX-QIRCYJPOSA-K 2-trans,6-trans,10-trans-geranylgeranyl diphosphate(3-) Chemical compound CC(C)=CCC\C(C)=C\CC\C(C)=C\CC\C(C)=C\COP([O-])(=O)OP([O-])([O-])=O OINNEUNVOZHBOX-QIRCYJPOSA-K 0.000 description 11
- 102000004190 Enzymes Human genes 0.000 description 11
- 108090000790 Enzymes Proteins 0.000 description 11
- 101150012639 HPPD gene Proteins 0.000 description 11
- 238000010367 cloning Methods 0.000 description 11
- 230000001939 inductive effect Effects 0.000 description 11
- 229930027917 kanamycin Natural products 0.000 description 11
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 11
- 229960000318 kanamycin Drugs 0.000 description 11
- 229930182823 kanamycin A Natural products 0.000 description 11
- 239000008188 pellet Substances 0.000 description 11
- 235000018102 proteins Nutrition 0.000 description 11
- 102000004169 proteins and genes Human genes 0.000 description 11
- 238000012546 transfer Methods 0.000 description 11
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 10
- 239000000463 material Substances 0.000 description 10
- 108020004705 Codon Proteins 0.000 description 9
- 244000038559 crop plants Species 0.000 description 9
- 235000021186 dishes Nutrition 0.000 description 9
- 229920001184 polypeptide Polymers 0.000 description 9
- LWTDZKXXJRRKDG-KXBFYZLASA-N (-)-phaseollin Chemical compound C1OC2=CC(O)=CC=C2[C@H]2[C@@H]1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-KXBFYZLASA-N 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 8
- 101710163504 Phaseolin Proteins 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- KWGKDLIKAYFUFQ-UHFFFAOYSA-M lithium chloride Chemical compound [Li+].[Cl-] KWGKDLIKAYFUFQ-UHFFFAOYSA-M 0.000 description 8
- 239000002207 metabolite Substances 0.000 description 8
- 230000025540 plastid localization Effects 0.000 description 8
- 239000000758 substrate Substances 0.000 description 8
- 230000005945 translocation Effects 0.000 description 8
- 150000007513 acids Chemical class 0.000 description 7
- XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 7
- 238000002474 experimental method Methods 0.000 description 7
- JLIDBLDQVAYHNE-YKALOCIXSA-N (+)-Abscisic acid Chemical compound OC(=O)/C=C(/C)\C=C\[C@@]1(O)C(C)=CC(=O)CC1(C)C JLIDBLDQVAYHNE-YKALOCIXSA-N 0.000 description 6
- 241000589158 Agrobacterium Species 0.000 description 6
- 240000007594 Oryza sativa Species 0.000 description 6
- 235000007164 Oryza sativa Nutrition 0.000 description 6
- 108010076504 Protein Sorting Signals Proteins 0.000 description 6
- 240000003768 Solanum lycopersicum Species 0.000 description 6
- 241001468227 Streptomyces avermitilis Species 0.000 description 6
- 150000001413 amino acids Chemical class 0.000 description 6
- 239000007640 basal medium Substances 0.000 description 6
- 230000006870 function Effects 0.000 description 6
- 235000012015 potatoes Nutrition 0.000 description 6
- 239000002243 precursor Substances 0.000 description 6
- 125000001844 prenyl group Chemical group [H]C([*])([H])C([H])=C(C([H])([H])[H])C([H])([H])[H] 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 235000009566 rice Nutrition 0.000 description 6
- 239000006228 supernatant Substances 0.000 description 6
- 241000219310 Beta vulgaris subsp. vulgaris Species 0.000 description 5
- 240000000385 Brassica napus var. napus Species 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 5
- 235000012766 Cannabis sativa ssp. sativa var. sativa Nutrition 0.000 description 5
- 235000012765 Cannabis sativa ssp. sativa var. spontanea Nutrition 0.000 description 5
- 108020004635 Complementary DNA Proteins 0.000 description 5
- 229920000742 Cotton Polymers 0.000 description 5
- 241000219146 Gossypium Species 0.000 description 5
- 235000003228 Lactuca sativa Nutrition 0.000 description 5
- 240000008415 Lactuca sativa Species 0.000 description 5
- 235000004431 Linum usitatissimum Nutrition 0.000 description 5
- 240000006240 Linum usitatissimum Species 0.000 description 5
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 5
- 235000021536 Sugar beet Nutrition 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 230000003115 biocidal effect Effects 0.000 description 5
- 235000009120 camo Nutrition 0.000 description 5
- 235000005607 chanvre indien Nutrition 0.000 description 5
- 238000012411 cloning technique Methods 0.000 description 5
- 239000011487 hemp Substances 0.000 description 5
- 230000014759 maintenance of location Effects 0.000 description 5
- 108020004707 nucleic acids Proteins 0.000 description 5
- 102000039446 nucleic acids Human genes 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- KJTLQQUUPVSXIM-ZCFIWIBFSA-M (R)-mevalonate Chemical compound OCC[C@](O)(C)CC([O-])=O KJTLQQUUPVSXIM-ZCFIWIBFSA-M 0.000 description 4
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108010066133 D-octopine dehydrogenase Proteins 0.000 description 4
- KJTLQQUUPVSXIM-UHFFFAOYSA-N DL-mevalonic acid Natural products OCCC(O)(C)CC(O)=O KJTLQQUUPVSXIM-UHFFFAOYSA-N 0.000 description 4
- YQYJSBFKSSDGFO-UHFFFAOYSA-N Epihygromycin Natural products OC1C(O)C(C(=O)C)OC1OC(C(=C1)O)=CC=C1C=C(C)C(=O)NC1C(O)C(O)C2OCOC2C1O YQYJSBFKSSDGFO-UHFFFAOYSA-N 0.000 description 4
- 108010074122 Ferredoxins Proteins 0.000 description 4
- 108010003581 Ribulose-bisphosphate carboxylase Proteins 0.000 description 4
- 241000209056 Secale Species 0.000 description 4
- 235000007238 Secale cereale Nutrition 0.000 description 4
- 241000700605 Viruses Species 0.000 description 4
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 4
- 238000007792 addition Methods 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 230000000692 anti-sense effect Effects 0.000 description 4
- 230000001851 biosynthetic effect Effects 0.000 description 4
- 239000000872 buffer Substances 0.000 description 4
- 235000005822 corn Nutrition 0.000 description 4
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 4
- 238000001514 detection method Methods 0.000 description 4
- 230000004927 fusion Effects 0.000 description 4
- WQYVRQLZKVEZGA-UHFFFAOYSA-N hypochlorite Chemical compound Cl[O-] WQYVRQLZKVEZGA-UHFFFAOYSA-N 0.000 description 4
- 238000002955 isolation Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 210000003470 mitochondria Anatomy 0.000 description 4
- 238000010369 molecular cloning Methods 0.000 description 4
- LWTDZKXXJRRKDG-UHFFFAOYSA-N phaseollin Natural products C1OC2=CC(O)=CC=C2C2C1C1=CC=C3OC(C)(C)C=CC3=C1O2 LWTDZKXXJRRKDG-UHFFFAOYSA-N 0.000 description 4
- 230000019525 primary metabolic process Effects 0.000 description 4
- 230000001850 reproductive effect Effects 0.000 description 4
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 230000008685 targeting Effects 0.000 description 4
- 230000002103 transcriptional effect Effects 0.000 description 4
- 238000011144 upstream manufacturing Methods 0.000 description 4
- 210000003934 vacuole Anatomy 0.000 description 4
- 238000005406 washing Methods 0.000 description 4
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 3
- AJPADPZSRRUGHI-RFZPGFLSSA-N 1-deoxy-D-xylulose 5-phosphate Chemical compound CC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O AJPADPZSRRUGHI-RFZPGFLSSA-N 0.000 description 3
- 101710099475 3'-phosphoadenosine 5'-phosphate phosphatase Proteins 0.000 description 3
- KKADPXVIOXHVKN-UHFFFAOYSA-N 4-hydroxyphenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=C(O)C=C1 KKADPXVIOXHVKN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 3
- 235000011293 Brassica napus Nutrition 0.000 description 3
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 3
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 3
- 101710196411 Fructose-1,6-bisphosphatase Proteins 0.000 description 3
- 101710186733 Fructose-1,6-bisphosphatase, chloroplastic Proteins 0.000 description 3
- 101710109119 Fructose-1,6-bisphosphatase, cytosolic Proteins 0.000 description 3
- 101710198902 Fructose-1,6-bisphosphate aldolase/phosphatase Proteins 0.000 description 3
- 240000004658 Medicago sativa Species 0.000 description 3
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 3
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 3
- 108020004511 Recombinant DNA Proteins 0.000 description 3
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
- 239000004098 Tetracycline Substances 0.000 description 3
- 241000723873 Tobacco mosaic virus Species 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 210000000172 cytosol Anatomy 0.000 description 3
- 230000001086 cytosolic effect Effects 0.000 description 3
- FCRACOPGPMPSHN-UHFFFAOYSA-N desoxyabscisic acid Natural products OC(=O)C=C(C)C=CC1C(C)=CC(=O)CC1(C)C FCRACOPGPMPSHN-UHFFFAOYSA-N 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 239000012636 effector Substances 0.000 description 3
- 239000003623 enhancer Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 108010002685 hygromycin-B kinase Proteins 0.000 description 3
- 238000000338 in vitro Methods 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000006870 ms-medium Substances 0.000 description 3
- 238000002703 mutagenesis Methods 0.000 description 3
- 231100000350 mutagenesis Toxicity 0.000 description 3
- 235000019175 phylloquinone Nutrition 0.000 description 3
- CBIDRCWHNCKSTO-UHFFFAOYSA-N prenyl diphosphate Chemical compound CC(C)=CCO[P@](O)(=O)OP(O)(O)=O CBIDRCWHNCKSTO-UHFFFAOYSA-N 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000002829 reductive effect Effects 0.000 description 3
- 238000005204 segregation Methods 0.000 description 3
- 230000004960 subcellular localization Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 229960002180 tetracycline Drugs 0.000 description 3
- 229930101283 tetracycline Natural products 0.000 description 3
- 235000019364 tetracycline Nutrition 0.000 description 3
- 150000003522 tetracyclines Chemical class 0.000 description 3
- 238000000844 transformation Methods 0.000 description 3
- 238000013519 translation Methods 0.000 description 3
- 150000003714 vitamin K1 derivatives Chemical class 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- WGVKWNUPNGFDFJ-DQCZWYHMSA-N β-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C WGVKWNUPNGFDFJ-DQCZWYHMSA-N 0.000 description 3
- QUEDXNHFTDJVIY-DQCZWYHMSA-N γ-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 QUEDXNHFTDJVIY-DQCZWYHMSA-N 0.000 description 3
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 3
- PRPINYUDVPFIRX-UHFFFAOYSA-N 1-naphthaleneacetic acid Chemical compound C1=CC=C2C(CC(=O)O)=CC=CC2=C1 PRPINYUDVPFIRX-UHFFFAOYSA-N 0.000 description 2
- OTXNTMVVOOBZCV-UHFFFAOYSA-N 2R-gamma-tocotrienol Natural products OC1=C(C)C(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-UHFFFAOYSA-N 0.000 description 2
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 2
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 2
- 244000144725 Amygdalus communis Species 0.000 description 2
- KHBQMWCZKVMBLN-UHFFFAOYSA-N Benzenesulfonamide Chemical compound NS(=O)(=O)C1=CC=CC=C1 KHBQMWCZKVMBLN-UHFFFAOYSA-N 0.000 description 2
- 108700010070 Codon Usage Proteins 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- GVVPGTZRZFNKDS-YFHOEESVSA-N Geranyl diphosphate Natural products CC(C)=CCC\C(C)=C/COP(O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-YFHOEESVSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- RRHGJUQNOFWUDK-UHFFFAOYSA-N Isoprene Chemical group CC(=C)C=C RRHGJUQNOFWUDK-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 101150000102 LEB4 gene Proteins 0.000 description 2
- 108090000856 Lyases Proteins 0.000 description 2
- 102000004317 Lyases Human genes 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- NWBJYWHLCVSVIJ-UHFFFAOYSA-N N-benzyladenine Chemical compound N=1C=NC=2NC=NC=2C=1NCC1=CC=CC=C1 NWBJYWHLCVSVIJ-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- 238000012300 Sequence Analysis Methods 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- 108091081024 Start codon Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 108010001244 Tli polymerase Proteins 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- RZFHLOLGZPDCHJ-DLQZEEBKSA-N alpha-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(/CC/C=C(\CC/C=C(\C)/C)/C)\C)(C)CCc2c1C RZFHLOLGZPDCHJ-DLQZEEBKSA-N 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- 125000003118 aryl group Chemical group 0.000 description 2
- 238000003287 bathing Methods 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- GPRBEKHLDVQUJE-VINNURBNSA-N cefotaxime Chemical compound N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C(O)=O)=O)C(=O)/C(=N/OC)C1=CSC(N)=N1 GPRBEKHLDVQUJE-VINNURBNSA-N 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 108010031100 chloroplast transit peptides Proteins 0.000 description 2
- 229940088530 claforan Drugs 0.000 description 2
- 238000012217 deletion Methods 0.000 description 2
- 230000037430 deletion Effects 0.000 description 2
- 208000018459 dissociative disease Diseases 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 235000010382 gamma-tocopherol Nutrition 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- GVVPGTZRZFNKDS-JXMROGBWSA-N geranyl diphosphate Chemical compound CC(C)=CCC\C(C)=C\CO[P@](O)(=O)OP(O)(O)=O GVVPGTZRZFNKDS-JXMROGBWSA-N 0.000 description 2
- 239000012869 germination medium Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012139 lysis buffer Substances 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000001404 mediated effect Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 150000002773 monoterpene derivatives Chemical class 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 2
- 229930015704 phenylpropanoid Natural products 0.000 description 2
- 150000002995 phenylpropanoid derivatives Chemical class 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000002441 reversible effect Effects 0.000 description 2
- 229960004889 salicylic acid Drugs 0.000 description 2
- 239000001632 sodium acetate Substances 0.000 description 2
- 235000017281 sodium acetate Nutrition 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 150000003612 tocotrienol derivatives Chemical class 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- RZFHLOLGZPDCHJ-XZXLULOTSA-N α-Tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C RZFHLOLGZPDCHJ-XZXLULOTSA-N 0.000 description 2
- FGYKUFVNYVMTAM-WAZJVIJMSA-N β-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-WAZJVIJMSA-N 0.000 description 2
- 239000002478 γ-tocopherol Substances 0.000 description 2
- OTXNTMVVOOBZCV-WAZJVIJMSA-N γ-tocotrienol Chemical compound OC1=C(C)C(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 OTXNTMVVOOBZCV-WAZJVIJMSA-N 0.000 description 2
- ODADKLYLWWCHNB-LDYBVBFYSA-N δ-tocotrienol Chemical compound OC1=CC(C)=C2O[C@@](CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-LDYBVBFYSA-N 0.000 description 2
- CABVTRNMFUVUDM-VRHQGPGLSA-N (3S)-3-hydroxy-3-methylglutaryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C[C@@](O)(CC(O)=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CABVTRNMFUVUDM-VRHQGPGLSA-N 0.000 description 1
- FGYKUFVNYVMTAM-UHFFFAOYSA-N (R)-2,5,8-trimethyl-2-(4,8,12-trimethyl-trideca-3t,7t,11-trienyl)-chroman-6-ol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-UHFFFAOYSA-N 0.000 description 1
- GTWCNYRFOZKWTL-UOFXASEASA-N (R,R)-2-methyl-6-phytylhydroquinone Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\CC1=CC(O)=CC(C)=C1O GTWCNYRFOZKWTL-UOFXASEASA-N 0.000 description 1
- YVLPJIGOMTXXLP-UUKUAVTLSA-N 15,15'-cis-Phytoene Natural products C(=C\C=C/C=C(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C)(\CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)/C YVLPJIGOMTXXLP-UUKUAVTLSA-N 0.000 description 1
- YVLPJIGOMTXXLP-UHFFFAOYSA-N 15-cis-phytoene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC(C)=CC=CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C YVLPJIGOMTXXLP-UHFFFAOYSA-N 0.000 description 1
- SUFZKUBNOVDJRR-HAVVHWLPSA-N 2,3-dimethyl-6-phytylhydroquinone Chemical compound CC(C)CCCC(C)CCCC(C)CCC\C(C)=C\CC1=CC(O)=C(C)C(C)=C1O SUFZKUBNOVDJRR-HAVVHWLPSA-N 0.000 description 1
- LTVDFSLWFKLJDQ-IEOSBIPESA-N 2-[(3r,7r,11r)-3-hydroxy-3,7,11,15-tetramethylhexadecyl]-3,5,6-trimethylcyclohexa-2,5-diene-1,4-dione Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-IEOSBIPESA-N 0.000 description 1
- BECBAQIAXDDXIE-UHFFFAOYSA-M 2-[3-[(4-amino-2-methylpyrimidin-5-yl)methyl]-2-(2-hydroxyethyl)-4-methyl-1,3-thiazol-3-ium-5-yl]ethanol;chloride Chemical compound [Cl-].CC1=C(CCO)SC(CCO)=[N+]1CC1=CN=C(C)N=C1N BECBAQIAXDDXIE-UHFFFAOYSA-M 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- ODADKLYLWWCHNB-UHFFFAOYSA-N 2R-delta-tocotrienol Natural products OC1=CC(C)=C2OC(CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1 ODADKLYLWWCHNB-UHFFFAOYSA-N 0.000 description 1
- IJJWOSAXNHWBPR-HUBLWGQQSA-N 5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]-n-(6-hydrazinyl-6-oxohexyl)pentanamide Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)NCCCCCC(=O)NN)SC[C@@H]21 IJJWOSAXNHWBPR-HUBLWGQQSA-N 0.000 description 1
- QRXMUCSWCMTJGU-UHFFFAOYSA-N 5-bromo-4-chloro-3-indolyl phosphate Chemical compound C1=C(Br)C(Cl)=C2C(OP(O)(=O)O)=CNC2=C1 QRXMUCSWCMTJGU-UHFFFAOYSA-N 0.000 description 1
- 241001605719 Appias drusilla Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 101000972350 Bombyx mori Lebocin-4 Proteins 0.000 description 1
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 description 1
- 240000003259 Brassica oleracea var. botrytis Species 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 241000192700 Cyanobacteria Species 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
- 108010020056 Hydrogenase Proteins 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 101710173432 Phytoene synthase Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- MEFKEPWMEQBLKI-AIRLBKTGSA-N S-adenosyl-L-methioninate Chemical compound O[C@@H]1[C@H](O)[C@@H](C[S+](CC[C@H](N)C([O-])=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 MEFKEPWMEQBLKI-AIRLBKTGSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- 108010006785 Taq Polymerase Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical group O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960001570 ademetionine Drugs 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 238000000246 agarose gel electrophoresis Methods 0.000 description 1
- 229940064063 alpha tocotrienol Drugs 0.000 description 1
- LTVDFSLWFKLJDQ-DKGMKSHISA-N alpha-Tocopherolquinone Natural products CC(C)CCC[C@H](C)CCC[C@@H](C)CCC[C@@](C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-DKGMKSHISA-N 0.000 description 1
- LTVDFSLWFKLJDQ-UHFFFAOYSA-N alpha-tocopheryl-para-quinone Natural products CC(C)CCCC(C)CCCC(C)CCCC(C)(O)CCC1=C(C)C(=O)C(C)=C(C)C1=O LTVDFSLWFKLJDQ-UHFFFAOYSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 229940019748 antifibrinolytic proteinase inhibitors Drugs 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940066595 beta tocopherol Drugs 0.000 description 1
- FGYKUFVNYVMTAM-YMCDKREISA-N beta-Tocotrienol Natural products Oc1c(C)c2c(c(C)c1)O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CC2 FGYKUFVNYVMTAM-YMCDKREISA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- GZCJJOLJSBCUNR-UHFFFAOYSA-N chroman-6-ol Chemical class O1CCCC2=CC(O)=CC=C21 GZCJJOLJSBCUNR-UHFFFAOYSA-N 0.000 description 1
- 238000003776 cleavage reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 238000006114 decarboxylation reaction Methods 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- BTNBMQIHCRIGOU-UHFFFAOYSA-N delta-tocotrienol Natural products CC(=CCCC(=CCCC(=CCCOC1(C)CCc2cc(O)cc(C)c2O1)C)C)C BTNBMQIHCRIGOU-UHFFFAOYSA-N 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 230000003828 downregulation Effects 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- FGYKUFVNYVMTAM-MUUNZHRXSA-N epsilon-Tocopherol Natural products OC1=CC(C)=C2O[C@@](CCC=C(C)CCC=C(C)CCC=C(C)C)(C)CCC2=C1C FGYKUFVNYVMTAM-MUUNZHRXSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- OTXNTMVVOOBZCV-YMCDKREISA-N gamma-Tocotrienol Natural products Oc1c(C)c(C)c2O[C@@](CC/C=C(\CC/C=C(\CC/C=C(\C)/C)/C)/C)(C)CCc2c1 OTXNTMVVOOBZCV-YMCDKREISA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 102000034356 gene-regulatory proteins Human genes 0.000 description 1
- 108091006104 gene-regulatory proteins Proteins 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 description 1
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 description 1
- 235000018977 lysine Nutrition 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000000520 microinjection Methods 0.000 description 1
- 238000000302 molecular modelling Methods 0.000 description 1
- 229930003658 monoterpene Natural products 0.000 description 1
- 235000002577 monoterpenes Nutrition 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000029553 photosynthesis Effects 0.000 description 1
- 238000010672 photosynthesis Methods 0.000 description 1
- 229940068065 phytosterols Drugs 0.000 description 1
- ITPLBNCCPZSWEU-PYDDKJGSSA-N phytyl diphosphate Chemical compound CC(C)CCC[C@@H](C)CCC[C@@H](C)CCC\C(C)=C\COP(O)(=O)OP(O)(O)=O ITPLBNCCPZSWEU-PYDDKJGSSA-N 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- GUUBJKMBDULZTE-UHFFFAOYSA-M potassium;2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid;hydroxide Chemical compound [OH-].[K+].OCCN1CCN(CCS(O)(=O)=O)CC1 GUUBJKMBDULZTE-UHFFFAOYSA-M 0.000 description 1
- 230000009993 protective function Effects 0.000 description 1
- 238000002731 protein assay Methods 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 229930004725 sesquiterpene Natural products 0.000 description 1
- 150000004354 sesquiterpene derivatives Chemical class 0.000 description 1
- JXOHGGNKMLTUBP-HSUXUTPPSA-N shikimic acid Chemical compound O[C@@H]1CC(C(O)=O)=C[C@@H](O)[C@H]1O JXOHGGNKMLTUBP-HSUXUTPPSA-N 0.000 description 1
- JXOHGGNKMLTUBP-JKUQZMGJSA-N shikimic acid Natural products O[C@@H]1CC(C(O)=O)=C[C@H](O)[C@@H]1O JXOHGGNKMLTUBP-JKUQZMGJSA-N 0.000 description 1
- 230000011664 signaling Effects 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 238000012090 tissue culture technique Methods 0.000 description 1
- 230000001052 transient effect Effects 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 235000019145 α-tocotrienol Nutrition 0.000 description 1
- 239000011730 α-tocotrienol Substances 0.000 description 1
- 235000007680 β-tocopherol Nutrition 0.000 description 1
- 239000011590 β-tocopherol Substances 0.000 description 1
- 235000019151 β-tocotrienol Nutrition 0.000 description 1
- 239000011723 β-tocotrienol Substances 0.000 description 1
- 235000019150 γ-tocotrienol Nutrition 0.000 description 1
- 239000011722 γ-tocotrienol Substances 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
- 235000019144 δ-tocotrienol Nutrition 0.000 description 1
- 239000011729 δ-tocotrienol Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0069—Oxidoreductases (1.) acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1022—Transferases (2.) transferring aldehyde or ketonic groups (2.2)
Definitions
- the present invention relates to the use of DNA sequences coding for a 1-deoxy-D-xylulose-5-phosphate synthase (DOXS) for the production of plants with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content, specifically the use of a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or a DNA sequence hybridizing with this, the use of a DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 and a DNA sequence SEQ-ID No.
- DOXS 1-deoxy-D-xylulose-5-phosphate synthase
- DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 a DNA sequence SEQ-ID No. 5 and a DNA sequence SEQ-ID No.
- ⁇ -Tocopherol is of great economic importance.
- Isoprenoids or terpenoids consist of different classes of lipid-soluble molecules and are partially or completely formed from Cs-isoprene units.
- Pure prenyl lipids e.g. carotenoids
- C skeletons which are exclusively based on isoprene units
- mixed prenyl lipids e.g. chlorophyll
- the starting point for the biosynthesis of prenyl lipids are 3 x acetyl-CoA units, which are converted via ß-hydroxymethylglutaryl-CoA (HMG-CoA) and mevalonate into the starting isoprene unit (C 5 ), the isopentenyl pyrophosphate (IPP). It has recently been shown by in vivo feeding experiments with C 13 that in various eubacteria, green algae and plant chloroplasts a Mevalonate-independent path to the formation of IPP is followed:
- Hydroxyethylthiamine which is formed by decarboxylation of pyruvate, and glyceraldehyde-3-phosphate (3-GAP) are mediated in a l-deoxy-D-xylulose-5-phosphate synthase
- IPP is in equilibrium with its isomer, dimethylallyl pyrophosphate (DMAPP).
- DMAPP dimethylallyl pyrophosphate
- GPP monoterpene
- FPP Farnesy pyrophosphate
- GGPP geranyl-geranyl pyrophosphate
- the ring structures of the mixed prenyl lipids that lead to the formation of vitamins E and K are quinones, the starting metabolites of which come from the Shikimate pathway.
- the aromatic amino acids phenylalanine and tyrosine are converted into hydroxyphenyl pyruvate, which is converted into homogenisic acid by dioxygenation. This is bound to PPP to form the precursor of ⁇ -tocopherol and ⁇ -tocoquinone, 2-methyl-6-phytylquinol.
- the object of the present invention was to develop a transgenic plant with an increased content of tocopherols, vitamin K, chlorophylls and carotenoids.
- the task was surprisingly achieved by overexpressing a 1-deoxy-D-xylulose-5-phosphate synthesis (DOXS) gene in the plants.
- DOXS 1-deoxy-D-xylulose-5-phosphate synthesis
- IPP in order to increase the metabolite flow from the primary metabolism into the isopronide metabolism, the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
- the activity of DOXS in plants was increased by overexpression of the homologous gene (gene from organism of the same type). This can also be achieved by expressing a heterologous gene (gene from distant organisms). Nucleotide sequences are described from Arabidopsis thaliana DOXS (Acc. No. U 27099), rice (Acc. No. AF024512) and peppermint (Acc. No. AF019383).
- the DOXS gene from Arabidopsis thaliana (SEQ ID No.:1; Mandel et al, Plant J. 9, 649-658 (1996); Acc. No. U27099) is expressed to a greater extent in transgenic plants. Plastid localization is ensured by the transit signal sequence contained in the gene sequence.
- a DNA sequence which codes for a DOXS gene which is identified by SEQ-ID No. 1 hybridizes and that comes from other organisms such as E. coli (SEQ-ID No. 3) or preferably from other plants.
- the GGPP which is now increasingly available, is being further converted towards tocopherols and carotenoids.
- carotenoids perform important protective functions against oxygen radicals, such as singlet oxygen, which they can return to the ground state (Asada, 1994; Demming-Adams and Adams, Trends in Plant Sciences 1; 21-26 (1996) 1-Deoxy-D-xyllos-5-phosphate synthase defective Arabidopsis thaliana mutant isolated, which shows an "albino phenotype" (Mandel et al, 1996). From this it can be deduced that a reduced amount of carotenoids in the plastids has negative effects on the plant.
- DOXS l-deoxy-D-xylulose-5-phosphate synthase
- HPPD p-hydroxyphenylpyruvate dioxygenase
- the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
- the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can be achieved by expressing homologous or other heterologous genes.
- D-1-deoxy-xylulose-5-phosphate is further converted towards tocopherols and carotenoids.
- homogentisic acid further increases the metabolite flow in the direction of phytylquinones and thus tocopherol, see Figure 1.
- Homogentisic acid is formed from p-hydroxyphenyl pyruvate by the enzyme p-hydroxyphenyl pyruvate dioxygenase (HPPD).
- HPPD p-hydroxyphenyl pyruvate dioxygenase
- the HPPD gene from Streptomyces avermitilis (Denoya et al., J. Bacteriol. 176 (1994),
- the transgenic plants are produced by transforming the plants with a construct containing the DOXS and HPPD genes.
- As model plants for the production of Tocopherols vitamin K, chlorophylls and carotenoids were used in tobacco and rapeseed.
- the invention also relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5, which code for a DOXS or HPPD or their functional equivalents, for producing a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
- the nucleic acid sequences can e.g. DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS or HPPD and which give the host the ability to overproduce tocopherol.
- an expression cassette also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
- an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the intermediate coding sequence for the DOXS or HPPD gene.
- An expression cassette is produced by fusing a suitable promoter with a suitable DOXS or HPPD DNA sequence and preferably a DNA inserted between the promoter and DOXS or HPPD DNA sequence which codes for a chloroplast-specific transit peptide, and a polyadenyly - Signaling according to common recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W.
- Transit peptides which controls the translocation of the polypeptide.
- Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS or HPPD part after translocation of the DOXS or HPPD gene into the chloroplasts.
- the transit peptide which is derived from plastid transketolase (TK) is particularly preferred. or a functional equivalent of this transit peptide (e.g. the transit peptide of the Rubisco small subunit or the
- Ferredoxin NADP oxidoreductase is derived.
- the fused expression cassette which codes for a DOXS gene and an HPPD gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
- Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants.
- the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
- the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
- Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
- the invention also relates to transgenic plants, transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 or hybridizing with these DNA sequences, as well as transgenic cells, tissues, parts and propagation material of such plants.
- Transgenic crop plants such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, AI falfa, lettuce and the various tree, nut and wine species.
- DOXS l-deoxy-D-xylulose-5-phosphate synthase
- GGPPOR geranylgeranyl pyrophosphate oxidoreductase
- the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
- the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can be achieved by expressing homologous or other heterologous genes.
- the activity of the enzyme geranylgeranyl pyrophosphate oxidoreductase is additionally increased in a further step of the invention by overexpression of a corresponding gene.
- an increased formation of phytyl pyrophosphate is achieved by an increased conversion of geranylgeranyl pyrophosphate to phytyl pyrophosphate.
- the GGPPOR gene from Arabidopsis thaliana (SEQ-ID No. 7) is increasingly expressed in transgenic plants.
- the Arabidopsis GGPPOR is preceded by a transit signal sequence.
- a DNA sequence which codes for a GGPPOR gene which is identified by SEQ-ID No. 7 hybridizes and that comes from other organisms or from other plants.
- Exemplary embodiment 15 describes the cloning of the GGPPOR gene from Arabidopsis thaliana.
- the transgenic plants are produced by transforming the plants with a construct containing the DOXS and GGPPOR genes.
- As model plants for the production of Tocopherols vitamin K, chlorophylls and carotenoids were used in tobacco and rapeseed.
- the invention relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 which code for a DOXS or GGPPOR or their functional equivalents, for the production of a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
- the nucleic acid sequences can e.g. DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS or GGPPOR and which give the host the ability to overproduce tocopherol.
- the expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
- an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and, if appropriate, further regulatory elements which are operatively linked to the intervening coding sequence for the DOXS or GGPPOR gene.
- An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
- sequences preferred but not limited to the operative linkage are targeting sequences to ensure the sub-cellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or other compartments and Translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693-8711).
- the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg.
- Fig. 2 shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
- any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
- a plant promoter or a promoter which originates from a plant virus is preferably used.
- the CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294). As is known, this promoter contains different recognition sequences for transcriptional effectors, which in their entirety lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
- the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS or GGPPOR gene in the plant can be controlled at a specific point in time.
- a chemically inducible promoter as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a promoter inducible by salicylic acid (WO 95/19443), one inducible by benzenesulfonamide (EP-A 388186), one inducible by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one inducible by abscisic acid (EP-A 335528) or inducible by ethanol or cyclohexanone ( WO 93/21334) promoters can include be used.
- promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that ensure leaf-specific expression should be mentioned in particular.
- the promoter of the cytosolic FBPase from potatoes or the ST-LSI promoter from potatoes should be mentioned (Stockhaus et al., EMBO J. 8 (1989), 2445-245).
- An expression cassette is produced by fusing a suitable promoter with a suitable DOXS or GGPPOR DNA sequence and preferably a DNA which is inserted between the promoter and DOXS or GGPPOR DNA sequence and which codes for a chloroplast-specific transit peptide and one Polyadenylation signal according to common recombination and cloning techniques, as described, for example, in T. Maniatis, EF Fritsch and J.
- Expression cassettes can also be used, the DNA sequence of which codes for a DOXS or GGPPOR fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
- Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS or GGPPOR part after translocation of the DOXS or GGPPOR gene into the chloroplasts.
- Particularly preferred is the transit peptide derived from plastid transketolase (TK) or a functional equivalent of this transit peptide (eg the transit peptide of the small subunit of the
- Rubisco or the ferredoxin NADP oxidoreductase is derived.
- the fused expression cassette which codes for a DOXS gene or a GGPPOR gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
- Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ ID No. 1 or SEQ ID No. 3, SEQ ID No. 7 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants.
- the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
- the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
- Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
- the invention also relates to transgenic plants transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants.
- Transgenic crop plants such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, AI falfa, lettuce and the various tree, nut and wine species.
- Process for transforming a plant is characterized in that expression cassettes containing a DNA sequence SEQ-ID No. 1 or a DNA sequence SEQ-ID No. 3 and a SEQ ID No. 7 or DNA sequences hybridizing with these zen into a plant cell, into callus tissue, an entire plant or protoplasts of plants.
- DOXS l-deoxy-D-xylulose-5-phosphate synthase
- HPPD p-hydroxyphenylpyruvate dioxygenase
- GGPPOR geranylgeranylpyrophosphate oxidoreductase
- the formation of IPP as a general starting substrate for all plastidic isoprenoids was increased.
- the activity of the DOXS in transgenic tobacco and rapeseed plants was increased by overexpression of the DOXS from E. coli. This can also be done by expressing homologous or other heterologous DOXS genes - such as a DNA sequence SEQ-ID No. 1 - can be achieved.
- the activity of the enzyme geranylgeranyl pyrophosphate oxidoreductase is additionally increased by overexpression of a corresponding homologous or heterologous gene in a further step which is essential to the invention.
- an increased formation of phytyl pyrophosphate is achieved by an increased conversion of geranylgeranyl pyrophosphate to phytyl pyrophosphate.
- the GGPPOR gene from Arabidopsis thaliana (SEQ-ID No. 7) is increasingly expressed in transgenic plants.
- the Arabidopsis GGPPOR is preceded by a transit signal sequence.
- a DNA sequence which codes for a GGPPOR gene which is identified by SEQ-ID No. 7 hybridizes and that comes from other organisms or from other plants.
- Exemplary embodiment 15 describes the cloning of the GGPPOR gene from Arabidopsis thaliana.
- HPPD p-hydroxyphenylpyruvate dioxygenase
- cDNAs coding for this enzyme have been described from various organisms such as, for example, from microorganisms, from plants and from humans.
- the cloning of the HPPD gene from Streptomyces avermitilis is described (Denoya et al., J. Bacteriol. 176 (1994), 5312-5319; SEQ ID No. 5).
- the HPPD from Streptomyces is preceded by a transit signal sequence.
- a DNA sequence which codes for an HPPD gene which is identified by SEQ-ID No. 5 hybridizes and that comes from other organisms or plants.
- the transgenic plants according to the invention are produced by transforming the plants with a construct containing the DOXS, the HPPD gene and the GGPPOR gene (Example 17). Tobacco and rapeseed were used as model plants for the production of tocopherols, vitamin K, chlorophylls and carotenoids.
- the invention relates to the use of the DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7, which code for a DOXS, an HPPD and a GGPPOR or their functional equivalents, for the production of a plant with increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
- the nucleic acid sequences can be, for example, DNA or cDNA sequences. Coding sequences suitable for insertion into an expression cassette are, for example, those which encode for a DOXS, an HPPD and a GGPPOR and which give the host the ability to overproduce tocopherol.
- an expression cassette also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
- an expression cassette comprises upstream, i.e. at the 5 'end of the coding sequence, a promoter and downstream, i.e. at the 3 'end, a polyadenylation signal and optionally further regulatory elements which are operatively linked to the intermediate coding sequence for the DOXS, the HPPD or the GGPPOR gene.
- An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements such that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
- sequences preferred but not limited to the operative linkage are targeting sequences to ensure the subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil corpuscles or others Compartments and translation enhancers such as the 5 'guiding sequence from the tobacco mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987), 8693-8711).
- the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg.
- Fig. 2 shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
- HPT hygromycin phosphotransferase
- OCS octopine synthase terminator
- PNOS nopalin synthase promoter - in addition, restriction sites are shown that only cut the vector once.
- any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
- a plant promoter or a plant virus-derived promoter is preferably used.
- the CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294).
- this promoter contains different recognition sequences for transcriptional effectors, which in their entirety lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
- the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS, HPPD or GGPPOR gene in the plant can be controlled at a specific point in time.
- a chemically inducible promoter by means of which the expression of the exogenous DOXS, HPPD or GGPPOR gene in the plant can be controlled at a specific point in time.
- promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a salicylic acid-inducible promoter (WO 95/19443), a benzene-sulfonamide-inducible promoter
- EP-A 388186 one that can be induced by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one that can be induced by abscisic acid (EP-A 335528) or that by ethanol or cyclohexanone-inducible (WO 93/21334) promoter can include be used.
- promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that ensure leaf-specific expression should be mentioned in particular.
- the promoter of the cytosolic FBPase from potato or the ST-LSI promoter from potato are to be mentioned (Stockhaus et al., EMBO J. 8 (1989), 2445-245).
- An expression cassette is produced by fusing a suitable promoter with a suitable DOXS, HPPD or GGPPOR DNA sequence and preferably a DNA inserted between promoter and DOXS, HPPD or GGPPOR DNA sequence, which is suitable for a chloroplast-specific transit peptide encoded, and a polyadenylation signal according to common recombination and cloning techniques, such as those described in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W.
- Expression cassettes whose DNA sequence codes for a DOXS, HPPD or GGPPOR fusion protein can also be used, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
- Preferred transit peptides are preferred for the chloroplasts, which are cleaved enzymatically from the DOXS, HPPD or GGPPOR part after translocation of the DOXS, HPPD or GGPPOR gene into the chloroplast.
- the transit peptide which is derived from plastid transketolase (TK) or a functional equivalent is particularly preferred.
- This transit peptide (for example the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase) is derived.
- the fused expression cassette which codes for a DOXS gene, an HPPD gene and a GGPPOR gene, is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
- Another object of the invention relates to the use of an expression cassette containing DNA sequences SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or with these hybridizing DNA sequences for transforming plants, cells, tissues or parts of plants.
- the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
- the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
- Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
- the invention also relates to transgenic plants, transformed with an expression cassette containing the sequence SEQ-ID No. 1 or SEQ-ID No. 3, SEQ ID No. 5 and SEQ-ID No. 7 or DNA sequences hybridizing with these, as well as transgenic cells, tissues, parts and propagation material of such plants.
- Transgenic crop plants such as e.g. Barley, wheat, rye, corn, oats, soy, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potato, tobacco, tomato, rapeseed, alfalfa, lettuce and the various tree, nut and wine species.
- DOXS gene from Arabidopsis or E. coli or DNA sequences hybridizing therewith and subsequent testing of chemicals for inhibition of DOXS enzyme activity.
- the transgenic plants are produced by transforming the plants with a construct containing the DOXS gene.
- Arabidopsis and oilseed rape were used as model plants for the production of tocopherols, vitamin K, chlorophylls and carotenoids.
- DOXS gene from Arabidopsis is cloned by isolating the cDNA specific for the DOXS gene (SEQ-ID No. 1).
- the invention relates to the use of the DNA sequence SEQ ID No. 1 or SEQ-ID No. 3 which codes for a DOXS or its functional equivalent, for the production of a plant with an increased tocopherol, vitamin K, chlorophyll and / or carotenoid content.
- the nucleic acid sequence can e.g. be a DNA or a cDNA sequence. Coding sequences suitable for insertion into an expression cassette are, for example, those which code for a DOXS and which give the host the ability to overproduce tocopherol.
- the expression cassettes also contain regulatory nucleic acid sequences which control the expression of the coding sequence in the host cell.
- an expression cassette comprises upstream, ie at the 5 'end of the coding sequence, a promoter and downstream, ie at the 3' end, a polyadenylation signal and, if appropriate, further regulatory elements which match the coding sequence for the DOXS gene in between are operationally linked.
- An operative link is understood to mean the sequential arrangement of promoter, coding sequence, terminator and, if appropriate, further regulatory elements in such a way that each of the regulatory elements can fulfill its function as intended when expressing the coding sequence.
- sequences preferred but not limited to the operative linkage are targeting sequences to ensure subcellular localization in the apoplast, in the vacuole, in plastids, in the mitochondrion, in the endoplasmic reticulum (ER), in the cell nucleus, in oil bodies or other compartments and translation enhancers like the 5 'guiding sequence from tobacco Mosaic virus (Gallie et al., Nucl. Acids Res. 15 (1987) 8693-8711).
- the plant expression cassette can be installed in the tobacco transformation vector pBinAR-Hyg.
- Fig. Shows the tobacco transformation vectors pBinAR-Hyg with 35S promoter (A) or pBinAR-Hyg with seed-specific promoter Phaseolin 796 (B):
- HPT hygromycin phosphotransferase - OCS: octopine synthase terminator PNOS: nopalin synthase promoter also such restriction sites are shown that only cut the vector once.
- any promoter which can control the expression of foreign genes in plants is suitable as promoters of the expression cassette.
- a plant promoter or a promoter derived from a plant virus is preferably used.
- the CaMV 35S promoter from the cauliflower mosaic virus is particularly preferred (Franck et al., Cell 21 (1980), 285-294).
- this promoter contains different recognition sequences for transcriptional effectors which, in their entirety, lead to permanent and constitutive expression of the introduced gene (Benfey et al., EMBO J. 8 (1989), 2195-2202).
- the expression cassette can also contain a chemically inducible promoter, by means of which the expression of the exogenous DOXS gene in the plant can be controlled at a specific point in time.
- a chemically inducible promoter by means of which the expression of the exogenous DOXS gene in the plant can be controlled at a specific point in time.
- promoters as e.g. the PRPl promoter (Ward et al., Plant. Mol. Biol. 22 (1993), 361-366), a promoter inducible by salicylic acid (WO 95/19443), one inducible by benzenesulfonamide (EP-A 388186 ), one that can be induced by tetracycline (Gatz et al., (1992) Plant J. 2, 397-404), one that can be induced by abscisic acid (EP-A 335528) or one that can be induced by ethanol or cyclohexanone (WO 93 / 21334)
- promoters are particularly preferred which ensure expression in tissues or parts of plants in which the biosynthesis of tocopherol or its precursors takes place. Promoters that are leaf-specific are particularly noteworthy Ensure expression.
- the promoter of the cytosolic FBPase from potatoes or the ST-LSI promoter from potatoes should be mentioned (Stockhaus et al., EMBO J. 8 (1989) 2445-245).
- the expression cassette can therefore, for example, be a seed-specific promoter (preferably the phaseolin
- An expression cassette is produced by fusing a suitable promoter with a suitable DOXS-DNA sequence and preferably a DNA inserted between promoter and DOXS-DNA sequence, which codes for a chloroplast-specific transit peptide, and a polyadenylation signal according to common recombination and cloning techniques, such as those for example in T. Maniatis, EF Fritsch and J. Sambrook, Molecular Cloning: A Laboratory Manual, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1989) and in T.J. Silhavy, M.L. Berman and L.W. Enquist, Experiments with Gene Fusions, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY (1984) and in Ausubel, F.M. et al. , Current Protocols in Molecular Biology, Greene Publishing Assoc. and Wiley-Interscience (1987).
- Sequences are particularly preferred which ensure targeting in the apoplasts, in plastids, in the vacuole, in the mitochondrion, in the endoplasmic reticulum (ER) or in the absence of corresponding operative sequences to ensure that they remain in the compartment of formation, the cytosol (Kermode, Crit. Rev. Plant Sei. 15, 4 (1996), 285-423). Localization in the ER has proven to be particularly beneficial for the amount of protein accumulation in transgenic plants (Schouten et al., Plant Mol. Biol. 30 (1996), 781-792).
- Expression cassettes can also be used, the DNA sequence of which codes for a DOXS fusion protein, part of the fusion protein being a transit peptide which controls the translocation of the polypeptide.
- Particularly preferred for the chloroplasts are specific transit peptides which, after translocation of the DOXS gene into the chloroplasts, are enzymatically removed from the DOXS part. will split.
- the transit peptide which is derived from the plastidic transketolase (TK) or a functional equivalent of this transit peptide (for example the transit peptide of the small subunit of the Rubisco or the ferredoxin NADP oxidoreductase) is particularly preferred.
- the inserted nucleotide sequence coding for a DOXS can be produced synthetically or obtained naturally or contain a mixture of synthetic and natural DNA components, as well as consist of different heterologous DOXS gene sections of different organisms.
- synthetic nucleotide sequences with codons are generated which are preferred by plants. These codons preferred by plants can be determined from codons with the highest protein frequency, which are expressed in most interesting plant species.
- various DNA fragments can be manipulated in order to obtain a nucleotide sequence which expediently reads in the correct direction and which is equipped with a correct reading frame.
- adapters or linkers can be attached to the fragments.
- the promoter and terminator regions can expediently be provided in the transcription direction with a linker or polylinker which contains one or more restriction sites for the insertion of this sequence.
- the linker has 1 to 10, usually 1 to 8, preferably 2 to 6, restriction sites.
- the linker has a size of less than 100 bp within the regulatory areas, often less than 60 bp, but at least 5 bp.
- the promoter can be native or homologous as well as foreign or heterologous to the host plant.
- the expression cassette contains in the 5 '-3' transcription direction the promoter, a DNA sequence which codes for a DOXS gene and a region for the transcriptional termination. Different termination areas are interchangeable.
- Preferred polyadenylation signals are plant polyadenylation signals, preferably those which essentially correspond to T-DNA polyadenylation signals from Agrobacterium tumefaciens, in particular gene 3 of T-DNA (octopine synthase) of the Ti plasmid pTiACH5 (Gielen et al., EMBO J. 3 (1984) 835 ff) or functional equivalents.
- An expression cassette can contain, for example, a constitutive promoter (preferably the CaMV 35 S promoter), the LeB4 signal peptide, the gene to be expressed and the ER retention signal.
- a constitutive promoter preferably the CaMV 35 S promoter
- the amino acid sequence KDEL lysine, aspartic acid, glutamic acid, leucine
- KDEL lysine, aspartic acid, glutamic acid, leucine
- the fused expression cassette which codes for a DOXS gene is preferably cloned into a vector, for example pBin19, which is suitable for transforming Agrobacterium tumefaciens.
- Agrobacteria transformed with such a vector can then be used in a known manner to transform plants, in particular crop plants, such as e.g. of tobacco plants can be used, for example by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
- the transformation of plants by agrobacteria is known, among other things, from F.F. White, Vectors for Gene Transfer in Higher Plants; in Transgenic Plants, Vol. 1, Engineering and Utilization, edited by S.D. Kung and R. Wu, Academic Press, 1993, pp. 15-38. From the transformed cells of the wounded leaves or leaf pieces, transgenic plants can be regenerated in a known manner which contain a gene integrated into the expression cassette for the expression of a DOXS gene contain.
- an expression cassette is inserted as an insert into a recombinant vector, the vector DNA of which contains additional functional regulatory signals, for example Contains sequences for replication or integration.
- additional functional regulatory signals for example Contains sequences for replication or integration.
- Suitable vectors are inter alia in "Methods in Plant Molecular Biology and Biotechnology" (CRC Press), Chap. 6/7, pp. 71-119 (1993).
- the expression cassettes can be cloned into suitable vectors that allow their proliferation, for example in E. coli.
- suitable cloning vectors include pBR332, pUC series, Ml3mp series and pACYC184.
- Binary vectors which can replicate both in E. coli and in agrobacteria are particularly suitable.
- Another object of the invention relates to the use of an expression cassette containing a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5; SEQ ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 7 or a DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 and SEQ-ID No. 5 and SEQ-ID No. 7, or with these hybridizing DNA sequences for the transformation of plants, cells, tissues or parts of plants.
- the aim of the use is preferably to increase the tocopherol, vitamin K, chlorophyll and carotenoid content of the plant.
- the expression can take place specifically in the leaves, in the seeds or in other parts of the plant.
- Such transgenic plants, their reproductive material and their plant cells, tissue or parts are a further subject of the present invention.
- the expression cassette can also be used to transform bacteria, cyanobacteria, yeast, filamentous fungi and algae with the aim of increasing tocopherol, vitamin K, chlorophyll and / or carotenoid production.
- transformation The transfer of foreign genes into the genome of a plant is called transformation.
- the methods described for the transformation and regeneration of plants from plant tissues or plant cells for transient or stable transformation are used. Suitable methods are protoplast transformation by polyethylene glycol-induced DNA uptake, the biolistic method with the gene cannon - the so-called particle bombardment method, electroporation, the incubation of dry embryos in DNA-containing solution, microinjection and the gene transfer mediated by Agrobacterium.
- the methods mentioned are described, for example, in B. Jenes et al., Techniques for Gene Transfer, in: Transgenic Plants, Vol. 1, Engineering and Utilization, edited by SD Kung and R. Wu, Academic Press (1993) 128-143 and in Potrykus Annu. Rev. Plant Physiol.
- the construct to be expressed is preferably cloned into a vector which is suitable for transforming Agro acteriu / n tumefaciens, for example pBin19 (Bevan et al., Nucl. Acids Res. 12 (1984) 8711).
- Agrobacteria transformed with an expression cassette can also be used in a known manner to transform plants, in particular crop plants, such as cereals, maize, oats, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes, rape, Alfalfa, lettuce and the various tree, nut and wine species can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
- crop plants such as cereals, maize, oats, soybeans, rice, cotton, sugar beet, canola, sunflower, flax, hemp, potatoes, tobacco, tomatoes, rape, Alfalfa, lettuce and the various tree, nut and wine species can be used, e.g. by bathing wounded leaves or leaf pieces in an agrobacterial solution and then cultivating them in suitable media.
- Functionally equivalent sequences which code for a DOXS gene are those sequences which, despite a different nucleotide sequence, still have the desired functions. Functional equivalents thus include naturally occurring variants of the sequences described herein as well as artificial, e.g. Artificial nucleotide sequences obtained by chemical synthesis and adapted to the codon use of a plant.
- a functional equivalent is also understood to mean, in particular, natural or artificial mutations in an originally isolated sequence coding for a DOXS, which furthermore show the desired function. Mutations include substitutions, additions, deletions, exchanges or insertions of one or more nucleotide residues.
- the present invention also encompasses those nucleotide sequences which are obtained by modifying the DOXS nucleotide sequence. The aim of such a modification can e.g. further narrowing down the coding sequence contained therein or e.g. also be the insertion of further restriction enzyme interfaces.
- Functional equivalents are also those variants whose function is weakened or enhanced compared to the original gene or gene fragment.
- artificial DNA sequences are suitable as long as they have the desired property, for example, of increasing the tocopherol content in the plant, as described above
- Such artificial DNA sequences can be Setting of proteins constructed using molecular modeling, which have DOXS activity or are determined by in vitro selection. Coding DNA sequences which are obtained by back-translating a polypeptide sequence according to the codon usage specific for the host plant are particularly suitable. The specific codon usage can easily be determined by a person skilled in plant genetic methods by computer evaluations of other, known genes of the plant to be transformed.
- Suitable equivalent nucleic acid sequences are sequences which code for fusion proteins, part of the fusion protein being a plant DOXS polypeptide or a functionally equivalent part thereof.
- the second part of the fusion protein can e.g. be another polypeptide with enzymatic activity or an antigenic polypeptide sequence that can be used to detect DOXS expression (e.g. myc-tag or his-tag).
- this is preferably a regulatory protein sequence, such as e.g. a signal or transit peptide that directs the DOXS protein to the desired site of action.
- the invention also relates to the expression products and fusion proteins produced according to the invention from a transit peptide and a polypeptide with DOXS activity.
- increasing the tocopherol, vitamin K, chlorophyll and / or carotenoid content means the artificially acquired ability to increase the biosynthetic capacity of these compounds by functional overexpression of the DOXS gene in the plant compared to the non-genetically modified plant for the duration of at least one generation of plants.
- the tocopherol biosynthesis site is generally the leaf tissue, so that leaf-specific expression of the DOXS gene is useful.
- the tocopherol biosynthesis need not be restricted to the leaf tissue, but can also be tissue-specific in all other parts of the plant - for example in fatty seeds.
- constitutive expression of the exogenous DOXS gene is advantageous.
- inducible expression may also appear desirable.
- the effectiveness of the expression of the transgenically expressed DOXS gene can be determined, for example, in vitro by proliferation of the shoot meristem.
- a change in the type and level of expression of the DOXS gene and its effect on the tocopherol Biosynthetic performance can be tested on test plants in greenhouse experiments.
- the invention also relates to transgenic plants transformed with an expression cassette containing the
- Plants in the sense of the invention are mono- and dicotyledonous plants or algae.
- the complete cDNA sequence of the Arabidopsis DOXS is cloned into an expression vector (pQE, Qiagen) and overexpressed in E. coli.
- the DOXS protein expressed with the aid of the expression cassette is particularly suitable for the detection of inhibitors specific for the DOXS.
- the DOXS can be used, for example, in an enzyme test in which the activity of the DOXS is determined in the presence and absence of the active substance to be tested. By comparing the two activity determinations, a qualitative and quantitative statement can be made about the inhibitory behavior of the active substance to be tested. Methods for determining the activity of DOXS are described (Putra et. Al., Tetrahedron Letters 39 (1998), 23-26; Sprenger et al., PNAS 94 (1997), 12857-12862).
- DNA sequence SEQ-ID No. 1 or SEQ-ID No. 3 or introduces a hybridizing DNA sequence into a plant cell, into callus tissue, an entire plant or plant protoplasts.
- cloning steps carried out in the context of the present invention such as, for example, restriction cleavages, agarose gel electrophoresis, purification of DNA fragments, transfer of nucleic acids to nitrocellulose and nylon membranes, linking of DNA fragments, transformation of E. coli cells, cultivation of bacteria Multiplication of phages and sequence analysis of recombinant DNA were carried out as in Sambrook et al. (1989) Cold Spring Harbor Laboratory Press; ISBN 0-87969-309-6).
- the bacterial strains used below (E. coli, XL-I Blue) were obtained from Stratagene.
- the agrobacterial strain used for plant transformation (Agrobacterium tumefaciens, C58C1 with the plasmid pGV2260 or pGV3850 can) was developed by Deblaere et al. in (Nucl. Acids Res. 13 (1985) 4777).
- the LBA4404 agrobacterial strain (Clontech) or other suitable strains can be used.
- the vectors pUC19 (Yanish-Perron, Gene 33 (1985), 103-119) pBluescript SK- (Stratagene), pGEM-T (Promega), pZerO (Invitrogen), pBinl9 (Bevan et al., Nucl. Acids Res. 12 (1984), 8711-8720) and pBinAR (Höfgen and Willmitzer, Plant Science 66 (1990), 221-230).
- the sequencing of recombinant DNA molecules was carried out using a laser fluorescence DNA sequencer from Licor (sold by MWG Biotech, Ebersbach) according to the method of Sanger (Sanger et al., Proc. Natl. Acad. Sci. USA 74 (1977), 5463 - 5467).
- the Arabisopsis thaliana DOXS gene was described in Mandel et al. (1996) described as a complete cDNA cloned into the vector pBluescript KS- (Stratagene).
- a 2.3 kb fragment (labeled F-23-C) was isolated via the pBluescript KS-Hincll (blunt-end) and Sacl interfaces. This sequence contains the complete DOXS cDNA including chloroplast transit peptide from the ATG start codon to an EcoRI interface that is 80 bp downstream of the stop codon.
- a culture of Escherichia coli XL1 Blue was grown in 300 ml Luria Broth medium for 12 hours at 37 ° C.
- the genomic DNA of the bacterium was isolated from this culture by first pelleting at 5000 revolutions in a Sorvall RC50 fugue
- the pellet was then resuspended in 1/30 volume of the original culture lysis buffer (25 mM EDTA, 0.5% SDS; 50 mM Tris HC1, pH 8.0). An equal volume of phenol / chloroform / isoamyl alcohol (25: 24: 1) was added and incubated at 70 degrees for 10 minutes. Subsequently, in a Heraeus under-table
- oligonucleotides were derived from the DNA sequence of the DOXS (Acc. Number AF035440), to which a BamHI at the 5 'end and an Xbal or another BamHI restriction site were added at the 3' end.
- DOXS Acc. Number AF035440
- the oligonucleotide at the 5 'end comprises the sequence 5' -A1GGATCCATGAGTTTT-GATATTGCCAAATAC-3 '
- the oligonucleotide at the 3 'end comprises the sequence 5' - ATTCT AG ATTATGCCAGCCAGGCCTTG- 3 'or 5'-ATG-GATCCTTATGCCAGCCAGGCCTTG -3 '(nucleotides 1845-1863 of the reverse complementary DNA sequence; written in italics) starting with the
- the PCR reaction with the two BamHI-containing oligonucleotides was carried out with the Pfu polymerase (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. 500 ng of the genomic DNA from E. coli were used as template.
- the PCR program was:
- the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was determined by sequencing.
- the BamHI fragment was isolated from the PCR script vector and ligated into a correspondingly cut Bin19 vector which additionally contains the transit peptide of the potato transketolase behind the CaMV 35S promoter. The transit peptide ensures plastid localization.
- the constructs are shown in Figures 5 and 6 and the fragments have the following meaning:
- Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
- Fragment B (259 bp) contains the transit peptide of the transketolase.
- Fragment E contains the gene of the DOXS.
- Fragment D (192 bp) contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
- the PCR reaction with the oligonucleotides containing 5 '-BamHI and 3' -Xbal was carried out using Taq polymerase (Takara, Sosei Co., Ltd.) according to the manufacturer's instructions. 500 ng of the genomic DNA from E. coli were used as template.
- the PCR program was:
- the fragment was purified using the gene clean kit and ligated into the vector pGemT (Promega GmbH, Mannheim). It was cloned as a BamHI / Xbal fragment into a correspondingly cut pBinl9AR vector behind the CaMV 35S promoter. The sequence was checked by sequencing (SEQ-ID No. 3) and two non-conservative base changes were found, which lead to a change in amino acid 152 (asparagine) in valine and amino acid 330 (cysteine) in tryptophan compared to the published sequence.
- RNA from 15 day old seedlings of different transgenic lines, which have the DOXS overexpression construct was determined according to the method of Logeman et al., Anal. Biochem. 163, 16-20 (1987) extracted, separated in a 1.2% agarose gel, transferred to filters and hybridized with a 2.1 kb long DOXS fragment as a probe ( Figure 7).
- transgenic rape plants The production of the transgenic rape plants is based on a protocol by Bade, JB and Damm, B (in Gene, Transfer to Plants, Potrykus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30-38 ), which also gives the composition of the media used.
- the transformations were carried out with the Agrobacterium strain LBA4404 (Clontech).
- the pBIN19 constructs already described above with the entire DOXS cDNA were used as binary vectors. In these pBIN vectors, the NOS terminator sequence was replaced by the OCR terminator sequence.
- Brassica napus seeds were sterilized with 70% (v / v) ethanol, washed for 10 min in 55 ° CH 2 0, in 1% hypochlorite solution (25% v / v Teepol, 0.1% v / v Twenn 20 ) incubated for 20 min and washed six times with sterile H0 for 20 min each.
- the seeds were dried on filter paper for three days and 10-15 seeds were germinated in a glass flask with 15 ml of germination medium.
- the roots and apices were removed from several seedlings (approx. 10 cm in size) and the remaining hypocotyls were cut into pieces approx. 6 mm long. The approx.
- 600 explants obtained in this way are washed with 50 ml of basal medium for 30 min and transferred to a 300 ml flask. After addition of 100 ml callus induction medium, the cultures were incubated for 24 h at 100 rpm.
- An overnight culture of the Agrobacterium strain was set up at 29 ° C. in LB with kanamycin (20 mg / l), of which 2 ml in 50 ml LB without kanamycin for 4 h at 29 ° C. up to an OD 60 o of 0.4- 0.5 incubated. After pelleting the culture at 2000 rpm for 25 min, the cell pellet was resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution was adjusted to an OD600 of 0.3 by adding further basal medium.
- the callus induction medium was removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution were added, mixed gently and incubated for 20 min.
- the Agrobacteria suspension was removed, the oilseed rape explants were washed for 1 min with 50 ml callus induction medium and then 100 ml callus induction medium was added.
- the co-cultivation was carried out on a rotary shaker at 100 rpm for 24 h. The co-cultivation was stopped by removing the callus induction medium and the explants were washed twice for 1 min with 25 ml and twice for 60 min with 100 ml washing medium at 100 rpm.
- the washing medium with the explants was transferred to 15 cm petri dishes and the medium was removed using sterile pipettes. distant.
- 20-30 explants were transferred to 90 mm petri dishes containing 25 ml shoot induction medium with kanamycin.
- the petri dishes were closed with two layers of leucopore and incubated at 25 ° C and 2000 lux for 16/8 H photoperiods. Every 12 days, the developing calli was transferred to fresh petri dishes with sprout induction medium. All further steps for the regeneration of whole plants were carried out as by Bade, JB and Damm, B. (in Gene Transfer to Plants, Potrycus, I. and Spangenberg, G., eds, Springer Lab Manual, Springer Verlag, 1995, 30- 38).
- the cDNA of DOXS (SEQ-ID No. 1) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter.
- the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed.
- Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
- Leaf disks with a diameter of 0.9 cm were taken from completely unfolded leaves from plants which contained the construct pBinAR HPPD-DOXS and were frozen in liquid nitrogen.
- the leaf material was homogenized in a HEPES-KOH buffer which contained proteinase inhibitors and the protein concentration was determined from the extract using the Bio-Rad protein assay according to the manufacturer's instructions.
- 45 ⁇ g protein of each extract were mixed with a volume of application buffer (Laemmli, 1970) and incubated for 5 min at 95 ° C. The proteins were then separated on a 12.5 percent SDS-PAGE gel. The proteins were then transferred to Porablot membrane (Machery and Nagel) using semi-dry electroblots.
- the DOXS protein was detected by means of an antibody against the E. coli DOXS from rabbits.
- the color reaction is based on the binding of a secondary antibody and an alkaline phosphatase, which converts NBT / BCIP into a dye.
- Secondary antibody and alkaline Phosphatase are from Pierce and were carried out according to the manufacturer's instructions.
- Figure 10 shows the detection of the DOXS protein in leaves of 5 transgenic plants.
- 1 marker; 2: plant 10; 3:62; 4: 63; 5: 69; 7:71; 8: 112; 9: 113; 10: 116; 11: WT1; 12: WT2; 13: 100 recombinant protein; 14:50ng recombinant protein; 15:10 ng recombinant protein.
- a culture of Streptomyces avermitilis U11864 was made in 300 ml of YEME medium (5 g malt extract, 2 g yeast extract, 2 g glucose)
- the genomic DNA of the bacterium was isolated from this culture by first pelleting it at 5000 U in a Sorvall RC5C fugue. The pellet was then resuspended in 1/30 volume of lysis buffer (25 mM EDTA, 0.5% SDS, 50 mM Tris-HCl, pH 8.0). An equal volume of phenol /
- the oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCAGCGGA - CAAGCCAAC-3 '(37 to 55 bases from the ATG in 5' direction; written in italics), the oligonucleotide at the 3 'end comprises the sequence
- the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) 10 and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was checked by sequencing. It was found that the isolated gene codes for an additional amino acid. It contains the three bases TAC (coding for tyrosine), 15 before the nucleotide N429 of the cited sequence (Denoya et al., 1994).
- the fragment was isolated from the vector with a BamHI and Xbal digest and into a correspondingly cut Bin19AR vector
- Fragment A (529 bp) contains the 35S promoter of the Cauliflower 30 mosaic virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic virus).
- Fragment B (259 bp) contains the transit peptide of the transketolase.
- Fragment C contains the HPPD gene.
- Fragment D (192 bp) contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen, J. et al., EMBO J. 3 (1984), 35 835-846) for transcription termination.
- a binary vector was prepared that contains both gene sequences ( Figure 13).
- the gene sequences of the DOXS 45 and the HPPD were each cloned as BamHI fragments as described in Examples 3 and 10.
- the vector pBinAR-Hyg contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
- the pBinAR-Hyg vector mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
- oligonucleotides were derived for a PCR, to which a BamHI restriction site had been added at the 5 'end and at the 3' end.
- the oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCTCCAGCGGACAAGCCAAC-3 '(nucleotides 37 to 55 from the ATG in 5' direction; italics)
- the oligonucleotide at the 3 'end comprises the sequence 5'-ATGGATC- CCGCGCCGCCTACAGGTTG-3 '(ending with base pair 1140 of the coding sequence, starting 8 base pairs 3' of the TAG stop codon; written in italics).
- the PCR reaction was carried out using Tli polymerase (Promega GmbH, Mannheim) according to the manufacturer's instructions. 10 ng of the plasmid pBinAR-HPPD were used as template.
- the PCR program was:
- the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The correctness of the sequence was checked by sequencing. It was cut out of the vector PCR script as a BamHI fragment and ligated into a correspondingly cut pBinAR vector, which additionally contains the transit peptide of transketolase, for introducing the gene product into the plastids. The plasmid pBinAR-TP-HPPD was formed ( Figure 12).
- the plasmid pBinAR-TP-HPPD was used to convert the 35S promoter, the transketolase transit peptide, the HPPD gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) isolated for transcription termination by means of PCR.
- a HindIII interface was added to each of the oligonucleotides for the promoter and the terminator.
- the sequence of the oligonucleotide which is attached to the 5 'region of the promoter is 5'-ATAAGCTT-CATGGAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the termination sequence (italics) is 5 '-ATAAGCTTGGACAATCAGTAAATTGAACGGAG-3'.
- the fragment obtained was purified using a gene clean kit (Dianova GmbH, Hilden) and according to the manufacturer's instructions in the vector PCR script (Stratagene GmbH, Heidelberg) cloned. The correctness of the sequence was checked by sequencing (SEQ-ID No. 5). From this PCR script vector, it was transferred as a Hindlll fragment into the correspondingly cut vector pBinl9 (Bevan, 1984, Nucleic 5 Acids Res. 12, 8711-8721).
- the plasmid pBinAR-TP-DOXS was used to convert the 35S promoter, the trans - ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al.,
- oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATGAATTCGGACAATCAGTAAATTGAA-CGGA-G-3'.
- the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned into the vector PCR script (Stratagene GmbH, Heidelberg) according to the manufacturer's instructions. The accuracy
- Fragment A (529 bp) contains the 35S promoter of the Cauliflower mosaic virus (nucleotides 6909 to 7437).
- Fragment B contains the transit peptide of plastid transketolase.
- Fragment C contains the gene of the HPPD.
- Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al.,
- Fragment E contains the gene of the DOXS.
- tobacco leaf disks were transformed with 45 sequences of the DOXS and the HPPD.
- 10 ml of an overnight culture of Agrobacterium tumefaciens grown under selection were centrifuged, the supernatant was discarded and the bacteria were resuspended in the same volume of antibiotic-free medium.
- Leaf disks of sterile plants (diameter approx. 1 cm) were bathed in this bacterial suspension in a sterile petri dish. The leaf disks were then placed in Petri dishes on MS medium (Murashige and Skoog, Physiol. Plant (1962) 15, 473) with 2% sucrose and 0.8% Bacto agar.
- transgenic rapeseed plants which have a changed prenyl lipid content
- the transformations were carried out with the Agrobacterium tumefaciens strain LBA4404 (Clontech GmbH, Heidelberg).
- the binary constructs already described above with the entire cDNAs of the DOXS and the HPPD were used as binary vectors.
- the NOS terminator sequence was replaced by the polyadenylation signal of gene 3 of the T-DNA of the ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
- Brassica napus seeds were sterilized with 70% (v / v) ethanol, washed for 10 min at 55 ° C in H0, in 1% hypochlorite solution (25% v / v Teepol, 0.1% v / v Tween 20 ) incubated for 20 min and washed six times with sterile H 2 0 for 20 min each.
- the seeds were dried on filter paper for three days and 10-15 seeds were germinated in a glass flask with 15 ml of germination medium.
- the roots and apices were removed from several seedlings (approx. 10 cm in size) and the remaining hypocotyls were cut into pieces approx. 6 mm long. The approx.
- 600 explants obtained in this way are washed with 50 ml of basal medium for 30 min and transferred to a 300 ml flask. After addition of 100 ml callus induction medium, the cultures were incubated for 24 h at 100 rpm. An overnight culture of the Agrobacterium strain was set up at 29 ° C. in Luria Broth medium with kanamycin (20 mg / 1), of which 2 ml in 50 ml Luria Broth medium without kanamycin for 4 h at 29 ° C. up to an OD 6 oo on 0.4 to 0.5 incubated. After pelleting the culture at 2000 rpm for 25 min, the cell pellet was resuspended in 25 ml of basal medium. The concentration of the bacteria in the solution was adjusted to an ODgoo of 0.3 by adding further basal medium.
- the callus induction medium was removed from the oilseed rape explants using sterile pipettes, 50 ml of Agrobacterium solution were added, mixed gently and incubated for 20 min.
- the Agrobacteria suspension was removed, the oilseed rape explant washed with 50 ml callus induction medium for 1 min and then 100 ml callus induction medium added.
- the co-cultivation was carried out on a rotary shaker at 100 rpm for 24 h.
- the co-cultivation was stopped by removing the callus induction medium and the explants were washed twice for 1 min with 25 ml and twice for 60 min with 100 ml washing medium at 100 rpm.
- the washing medium with the explants was in 15 cm
- the cDNA of DOXS (SEQ-ID No. 3) and HPPD (SEQ-ID No. 5) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter.
- the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed.
- Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all In some cases, the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
- RNA 20 ⁇ g of total RNA were first mixed with 3.3 ⁇ l of 3M sodium acetate solution and 2 ⁇ l of IM magnesium sulfate solution and made up to 100 ⁇ l of final volume with DEPC water. 1 ⁇ l of RNase-free DNase (Boehringer Mannheim) was added and incubated at 37 ° C. for 45 min. After removing the enzyme by shaking with phenol / chloroform / isoamyl alcohol, the RNA was precipitated with ethanol and the pellet was taken up in 100 ⁇ l DEPC water. 2.5 ⁇ g RNA from this solution were transcribed into cDNA using a cDNA kit (Gibco, Life Technologies).
- a cDNA kit Gibco, Life Technologies
- the oligonucleotide at the 5 'end comprises the sequence 5' -ATGGATCCATGGCGACGACGGTTACAC C-3 'starting with the first codon of the cDNA (printed in italics), the oligonucleotide at the 3' end comprises the sequence 5 '-ATGTCGACGTGATGA- TAGATTACTAACAGAC-3 'starting with base pair 1494 of the cDNA sequence (printed in italics).
- PCR reaction was carried out using Pfu polymerase from Strategagene GmbH, Heidelberg, according to the manufacturer's instructions. 1/8 volume of the cDNA was used as template (corresponds to 0.3 ⁇ g RNA).
- the PCR program was:
- the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the fragment was checked by sequencing (SEQ ID No. 7).
- the gene was cloned as a BamHI / SalI fragment into the correspondingly cut vector BinAR-Hyg by means of the restriction cut sections added to the sequence by the primers.
- This contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., EMBO J. 3 (1984), 835-846) for transcription termination.
- the plasmid imparts resistance to the antibiotic hygromycin in plants and is thus suitable for superinfecting plants with kanamycin resistance. Since the plastid transit peptide is
- GGPPOR was also cloned, the protein should be transported to the plastids in transgenic plants.
- the construct is shown in Figure 14.
- the fragments have the following meaning:
- Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
- Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
- Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
- a binary vector was prepared that contains both gene sequences ( Figure 15).
- the GGPPOR gene with the intrinsic plastid localization sequence was (as described in Example 15) as a BamHI / Sall fragment in the corresponding cloned vector pBinAR-Hyg cloned.
- the gene of the DOXS was cloned as a BamHI fragment as described in Example 3.
- the vector pBinAR-Hyg contains the 35S promoter of the cauliflower mosaic virus and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination. This plasmid mediates resistance to the antibiotic hygromycin in plants and is therefore suitable for superinfecting plants with kanamycin resistance.
- the plasmid pBinAR-TP-DOXS became the 35S promoter, the trans-ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination isolated by PCR.
- An EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence.
- the sequence of the oligonucleotide which is attached to the promoter is 5 '-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATGAATTCGGACAATCAGTAAATTGAACGGA-.
- the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an EcoRI fragment into the correspondingly cut vector pBin19 (Bevan, Nucleic Acids Res. 12 (1984), 8711-8721).
- the 35S promoter, the GGPPOR gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) were isolated from the plasmid pBinARHyg-GGPPOR for PCR transcription termination.
- An Xbal interface was added to each of the oligonucleotides for the promoter and the terminator.
- the sequence of the oligonucleotide which is attached to the promoter is 5 '-ATTCTAGAC ⁇ TG- GAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5 '-ATTCTAGAGGACAA-TCAGGAGAATT 3 '.
- the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an Xbal fragment into the correspondingly cut vector, which already contained the sequence of the DOXS as described above.
- Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
- Fragment B contains the transit peptide of the plastid transketolase.
- Fragment E contains the gene of the DOXS.
- Fragment D 5 contains the polyadenylation signal of gene 3 of the T-DNA of the ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
- Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
- oligonucleotides were derived for a PCR, to which a BamHI restriction site had been added at the 5 'end and at the 3' end.
- the oligonucleotide at the 5 'end comprises the sequence 5' -GGATCCTCCAGCGGACAAGCCAAC-3 '(nucleotides 37 to 55 from the ATG in 5' direction; written in italics), the 30 oligonucleotide at the 3 'end comprises the sequence 5'-ATGGATC -
- the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of sequence 45 was checked by sequencing. It was cut out as a BamHI fragment from the vector PCR script and ligated into a correspondingly cut pBinAR vector which additionally contains the Transketolase transit peptide contains, for the introduction of the gene product in the plastids. The plasmid pBinAR-TP-p-HPPD was formed.
- the plasmid pBinAR-TP-HPPD was used to convert the 35S promoter, the transketolase transit peptide, the p-HPPD gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid PTIACH5 (Gielen et al. 1984 ) for transcription termination by means of PCR.
- a HindIII interface was added to each of the oligonucleotides for the promoter and the terminator.
- the sequence of the oligonucleotide which is attached to the 5 'region of the promoter is 5'-ATAAGCTT-CATGGAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the termination sequence (italics) is 5 ' -ATAAGCTTGGAC-AATCAGTAAATTGAACGGAG-3 '.
- the fragment obtained was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. From this PCR script vector it was transferred as a HindIII fragment into the correspondingly cut vector pBin19 (Bevan, 1984, Nucleic Acids Res. 12, 8711-8721).
- the plasmid pBinAR-TP-DOXS became the 35S promoter, the trans - ketolase transit peptide, the DOXS gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination isolated by PCR.
- An EcoRI site was added to each of the oligonucleotides for the promoter and the terminator sequence.
- the sequence of the oligonucleotide, which is attached to the promoter (italics) is 5'-ATGAATTCCATGGAGTCAAAGATTCAAATAGA-3 ', that of the oligonucleotide, which is attached to the terminator sequence (italics) is 5' -ATGAATTCGGACAATC ⁇ GA- GTAAATTGAAC .
- the fragment was cleaned using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing. It was transferred from the PCR script vector as an EcoRI fragment into the correspondingly cut vector, which already contained the sequence of the HPPD as described above.
- the 35S promoter, the GGPPOR gene and the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 were isolated from the plasmid pBinARHyg-GGPPOR for transcription termination by means of PCR.
- An Xbal interface was added to each of the oligonucleotides for the promoter and the terminator.
- the sequence of the oligonucleotide, which is located at the The promoter (written in italics) is 5 '-ATTCTAGACATG-GAGTCAAA-GATTCAAATAGA-3', that of the oligonucleotide which is attached to the terminator sequence (italics) is 5'-ATTCTAGAGGACAA-TCAGTAAATTGAACGGAG-3 '.
- the fragment was purified using a gene clean kit (Dianova GmbH, Hilden) and cloned according to the manufacturer's instructions into the vector PCR script from Stratagene GmbH, Heidelberg. The correctness of the sequence was checked by sequencing.
- Fragment A (529 bp) contains the 35S promoter of the Cauliflower Mosaic Virus (nucleotides 6909 to 7437 of the Cauliflower Mosaic Virus).
- Fragment B contains the transit peptide of the plastid transketolase.
- Fragment C contains the gene of the HPPD.
- Fragment D contains the polyadenylation signal of gene 3 of the T-DNA of the Ti plasmid pTIACH5 (Gielen et al., 1984) for transcription termination.
- Fragment E contains the gene of the DOXS. Fragment F contains the gene of the GGPPOR including the intrinsic plastid transit sequence.
- the cDNA of DOXS (SEQ-ID No. 3) and GGPPOR (SEQ-ID No. 7) was provided with a CaMV35S promoter and overexpressed in rapeseed using the 35S promoter.
- the seed-specific promoter of the phaseolin gene was used to specifically increase the tocopherol content in the rapeseed.
- Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
- the cDNA of DOXS (SEQ-ID No. 3), HPPD (SEQ-ID No. 5) and GGPPOR (SEQ-ID No. 7) was provided with a CaMV35S promoter and in rapeseed using the 35S promoter overexpressed.
- the seed-specific promoter of the phaseolin gene was used to specifically determine the tocopherol content in the rapeseed to increase.
- Rapeseed plants transformed with the appropriate constructs were grown in the greenhouse. The ⁇ -tocopherol content of the whole plant or the seeds of the plant was then determined. In all cases the ⁇ -tocopherol concentration was increased compared to the non-transformed plant.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Cell Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU54157/99A AU757440B2 (en) | 1998-08-05 | 1999-07-30 | DNA sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
CA002339519A CA2339519A1 (en) | 1998-08-05 | 1999-07-30 | Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
JP2000563793A JP2002525034A (en) | 1998-08-05 | 1999-07-30 | DNA sequence encoding 1-deoxy-D-xylulose-5-phosphate synthase and its overproduction in plants |
EP99940083A EP1102852A1 (en) | 1998-08-05 | 1999-07-30 | Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1998135219 DE19835219A1 (en) | 1998-08-05 | 1998-08-05 | Use of 1-deoxy-D-xylulose-5-phosphate synthase DNA to produce plants with increased tocopherol, vitamin K, chlorophyll and/or carotenoid content |
DE19845216.0 | 1998-10-01 | ||
DE19845231.4 | 1998-10-01 | ||
DE1998145231 DE19845231A1 (en) | 1998-10-01 | 1998-10-01 | Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content |
DE1998145224 DE19845224A1 (en) | 1998-10-01 | 1998-10-01 | Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content |
DE19845224.1 | 1998-10-01 | ||
DE19835219.0 | 1998-10-01 | ||
DE1998145216 DE19845216A1 (en) | 1998-10-01 | 1998-10-01 | Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2000008169A1 true WO2000008169A1 (en) | 2000-02-17 |
WO2000008169A8 WO2000008169A8 (en) | 2000-05-04 |
Family
ID=27438844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP1999/005467 WO2000008169A1 (en) | 1998-08-05 | 1999-07-30 | Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1102852A1 (en) |
JP (1) | JP2002525034A (en) |
AU (1) | AU757440B2 (en) |
CA (1) | CA2339519A1 (en) |
WO (1) | WO2000008169A1 (en) |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044912A1 (en) * | 1999-01-28 | 2000-08-03 | Royal Holloway And Bedford New College | Manipulating isoprenoid expression |
WO2000044911A1 (en) * | 1999-01-29 | 2000-08-03 | Basf Aktiengesellschaft | Overexpression of a dna sequence coding for a transketolase in plants |
WO2001012827A3 (en) * | 1999-08-11 | 2001-08-23 | Sungene Gmbh & Co Kgaa | Method for production of transgenic plants with increased tocopherol content |
US6326164B1 (en) * | 2000-07-27 | 2001-12-04 | Paradigm Genetics, Inc. | Methods for determining deoxyxylulose 5-phosphate synthase activity |
WO2002000901A1 (en) * | 2000-06-29 | 2002-01-03 | Sungene Gmbh & Co. Kgaa | Changing the fine chemical content in organisms by genetically modifying the shikimate pathway |
WO2001073031A3 (en) * | 2000-03-28 | 2003-01-23 | Corixa Corp | Compositions and methods for the therapy and diagnosis of ovarian cancer |
WO2002012478A3 (en) * | 2000-08-07 | 2003-07-03 | Monsanto Technology Llc | Methyl-d-erythritol phosphate pathway genes |
US6632630B2 (en) | 2000-03-29 | 2003-10-14 | Aclara Biosciences, Inc. | Monooxygenase assays |
WO2002072848A3 (en) * | 2001-03-09 | 2003-10-30 | Sungene Gmbh & Co Kgaa | Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
FR2844142A1 (en) * | 2002-09-11 | 2004-03-12 | Bayer Cropscience Sa | Transformed plants or cells, useful for prenylquinone production and resistant to specific herbicides, overexpress prephenate dehydrogenase and p-hydroxyphenyl- pyruvate dioxygenase |
WO2004058934A2 (en) * | 2002-12-23 | 2004-07-15 | Sungene Gmbh & Co. Kgaa | Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
EP1072683A4 (en) * | 1998-04-14 | 2004-10-06 | Kyowa Hakko Kogyo Kk | METHOD FOR PRODUCING ISOPRENOID COMPOUNDS USING MICROORGANISMS AND METHOD FOR DETECTING COMPOUNDS HAVING ANTIBACTERIAL OR HERBICIDE ACTION |
US6872815B1 (en) | 2000-10-14 | 2005-03-29 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
US7067647B2 (en) | 1999-04-15 | 2006-06-27 | Calgene Llc | Nucleic acid sequences to proteins involved in isoprenoid synthesis |
US7112717B2 (en) | 2002-03-19 | 2006-09-26 | Monsanto Technology Llc | Homogentisate prenyl transferase gene (HPT2) from arabidopsis and uses thereof |
US7161061B2 (en) | 2001-05-09 | 2007-01-09 | Monsanto Technology Llc | Metabolite transporters |
US7230165B2 (en) | 2002-08-05 | 2007-06-12 | Monsanto Technology Llc | Tocopherol biosynthesis related genes and uses thereof |
US7238855B2 (en) | 2001-05-09 | 2007-07-03 | Monsanto Technology Llc | TyrA genes and uses thereof |
US7244877B2 (en) | 2001-08-17 | 2007-07-17 | Monsanto Technology Llc | Methyltransferase from cotton and uses thereof |
US7262339B2 (en) | 2001-10-25 | 2007-08-28 | Monsanto Technology Llc | Tocopherol methyltransferase tMT2 and uses thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007244240A (en) * | 2006-03-14 | 2007-09-27 | Hamamatsu Kagaku Gijutsu Kenkyu Shinkokai | Method for producing green callus cell |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0723017A2 (en) * | 1995-01-23 | 1996-07-24 | Basf Aktiengesellschaft | Transketolase |
WO1997027285A1 (en) * | 1996-01-29 | 1997-07-31 | Arizona Board Of Regents, On Behalf Of University Of Arizona | Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase |
WO1998006862A1 (en) * | 1996-08-09 | 1998-02-19 | Calgene Llc | Methods for producing carotenoid compounds and speciality oils in plant seeds |
WO1999011757A1 (en) * | 1997-09-02 | 1999-03-11 | Washington State University Research Foundation | NUCLEIC AND AMINO ACID SEQUENCES FOR A NOVEL TRANSKETOLASE FROM $i (MENTHA PIPERITA) |
DE19752700A1 (en) * | 1997-11-28 | 1999-06-02 | Hoechst Schering Agrevo Gmbh | 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators |
WO1999052938A2 (en) * | 1998-04-14 | 1999-10-21 | Jomaa Hassan | Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites |
-
1999
- 1999-07-30 EP EP99940083A patent/EP1102852A1/en not_active Withdrawn
- 1999-07-30 CA CA002339519A patent/CA2339519A1/en not_active Abandoned
- 1999-07-30 JP JP2000563793A patent/JP2002525034A/en active Pending
- 1999-07-30 AU AU54157/99A patent/AU757440B2/en not_active Ceased
- 1999-07-30 WO PCT/EP1999/005467 patent/WO2000008169A1/en not_active Application Discontinuation
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0723017A2 (en) * | 1995-01-23 | 1996-07-24 | Basf Aktiengesellschaft | Transketolase |
WO1997027285A1 (en) * | 1996-01-29 | 1997-07-31 | Arizona Board Of Regents, On Behalf Of University Of Arizona | Cloned plant p-hydroxyphenyl pyruvic acid dioxygenase |
WO1998006862A1 (en) * | 1996-08-09 | 1998-02-19 | Calgene Llc | Methods for producing carotenoid compounds and speciality oils in plant seeds |
WO1999011757A1 (en) * | 1997-09-02 | 1999-03-11 | Washington State University Research Foundation | NUCLEIC AND AMINO ACID SEQUENCES FOR A NOVEL TRANSKETOLASE FROM $i (MENTHA PIPERITA) |
DE19752700A1 (en) * | 1997-11-28 | 1999-06-02 | Hoechst Schering Agrevo Gmbh | 1-Deoxy-D-xylulose-5-phosphate synthase protein and modulators |
WO1999052938A2 (en) * | 1998-04-14 | 1999-10-21 | Jomaa Hassan | Identification of chemical active agents for inhibiting the 1-desoxy-d-xylulose-5-phosphate biosynthetic pathway in parasites |
Non-Patent Citations (5)
Cited By (40)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7531333B2 (en) | 1998-04-14 | 2009-05-12 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
US7364885B2 (en) | 1998-04-14 | 2008-04-29 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
US7132268B2 (en) | 1998-04-14 | 2006-11-07 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
US7208298B2 (en) | 1998-04-14 | 2007-04-24 | Kyowa Hakko Kogyo Co., Ltd. | Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
EP1072683A4 (en) * | 1998-04-14 | 2004-10-06 | Kyowa Hakko Kogyo Kk | METHOD FOR PRODUCING ISOPRENOID COMPOUNDS USING MICROORGANISMS AND METHOD FOR DETECTING COMPOUNDS HAVING ANTIBACTERIAL OR HERBICIDE ACTION |
WO2000044912A1 (en) * | 1999-01-28 | 2000-08-03 | Royal Holloway And Bedford New College | Manipulating isoprenoid expression |
WO2000044911A1 (en) * | 1999-01-29 | 2000-08-03 | Basf Aktiengesellschaft | Overexpression of a dna sequence coding for a transketolase in plants |
US7067647B2 (en) | 1999-04-15 | 2006-06-27 | Calgene Llc | Nucleic acid sequences to proteins involved in isoprenoid synthesis |
US7265207B2 (en) | 1999-04-15 | 2007-09-04 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
US7141718B2 (en) | 1999-04-15 | 2006-11-28 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
US7335815B2 (en) | 1999-04-15 | 2008-02-26 | Calgene Llc | Nucleic acid sequences to proteins involved in isoprenoid synthesis |
WO2001012827A3 (en) * | 1999-08-11 | 2001-08-23 | Sungene Gmbh & Co Kgaa | Method for production of transgenic plants with increased tocopherol content |
WO2001073031A3 (en) * | 2000-03-28 | 2003-01-23 | Corixa Corp | Compositions and methods for the therapy and diagnosis of ovarian cancer |
US6632630B2 (en) | 2000-03-29 | 2003-10-14 | Aclara Biosciences, Inc. | Monooxygenase assays |
WO2002000901A1 (en) * | 2000-06-29 | 2002-01-03 | Sungene Gmbh & Co. Kgaa | Changing the fine chemical content in organisms by genetically modifying the shikimate pathway |
US7332649B2 (en) | 2000-06-29 | 2008-02-19 | Sungene Gmbh & Co. Kgaa | Changing the fine chemical content in organisms by genetically modifying the shikimate pathway |
US6326164B1 (en) * | 2000-07-27 | 2001-12-04 | Paradigm Genetics, Inc. | Methods for determining deoxyxylulose 5-phosphate synthase activity |
US6841717B2 (en) | 2000-08-07 | 2005-01-11 | Monsanto Technology, L.L.C. | Methyl-D-erythritol phosphate pathway genes |
US7405343B2 (en) | 2000-08-07 | 2008-07-29 | Monsanto Technology Llc | Methyl-D-erythritol phosphate pathway genes |
WO2002012478A3 (en) * | 2000-08-07 | 2003-07-03 | Monsanto Technology Llc | Methyl-d-erythritol phosphate pathway genes |
US6872815B1 (en) | 2000-10-14 | 2005-03-29 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
US7420101B2 (en) | 2000-10-14 | 2008-09-02 | Calgene Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
US8362324B2 (en) | 2000-10-14 | 2013-01-29 | Monsanto Technology Llc | Nucleic acid sequences to proteins involved in tocopherol synthesis |
US7348167B2 (en) | 2001-03-09 | 2008-03-25 | Sungene Gmbh & Co. Kgaa | Increase in the vitamin E content in organisms due to an increase in the tyrosine aminotransferase activity |
WO2002072848A3 (en) * | 2001-03-09 | 2003-10-30 | Sungene Gmbh & Co Kgaa | Increase in the vitamin e content in organisms due to an increase in the tyrosine aminotransferase activity |
US7161061B2 (en) | 2001-05-09 | 2007-01-09 | Monsanto Technology Llc | Metabolite transporters |
US7238855B2 (en) | 2001-05-09 | 2007-07-03 | Monsanto Technology Llc | TyrA genes and uses thereof |
US7595382B2 (en) | 2001-08-17 | 2009-09-29 | Monsanto Technology Llc | Gamma tocopherol methyltransferase coding sequences from Brassica and uses thereof |
US7553952B2 (en) | 2001-08-17 | 2009-06-30 | Monsanto Technology Llc | Gamma tocopherol methyltransferase coding sequence identified in Cuphea and uses thereof |
US7605244B2 (en) | 2001-08-17 | 2009-10-20 | Monsanto Technology Llc | Gamma tocopherol methyltransferase coding sequence from Brassica and uses thereof |
US7244877B2 (en) | 2001-08-17 | 2007-07-17 | Monsanto Technology Llc | Methyltransferase from cotton and uses thereof |
US7262339B2 (en) | 2001-10-25 | 2007-08-28 | Monsanto Technology Llc | Tocopherol methyltransferase tMT2 and uses thereof |
US7112717B2 (en) | 2002-03-19 | 2006-09-26 | Monsanto Technology Llc | Homogentisate prenyl transferase gene (HPT2) from arabidopsis and uses thereof |
US7230165B2 (en) | 2002-08-05 | 2007-06-12 | Monsanto Technology Llc | Tocopherol biosynthesis related genes and uses thereof |
WO2004024928A3 (en) * | 2002-09-11 | 2004-04-22 | Bayer Cropscience Sa | Transformed plants with enhanced prenylquinone biosynthesis |
WO2004024928A2 (en) * | 2002-09-11 | 2004-03-25 | Bayer Cropscience S.A. | Transformed plants with enhanced prenylquinone biosynthesis |
FR2844142A1 (en) * | 2002-09-11 | 2004-03-12 | Bayer Cropscience Sa | Transformed plants or cells, useful for prenylquinone production and resistant to specific herbicides, overexpress prephenate dehydrogenase and p-hydroxyphenyl- pyruvate dioxygenase |
US10138490B2 (en) | 2002-09-11 | 2018-11-27 | Michel Matringe | Transformed plants tolerant to herbicides due to overexpression of prephenate dehydrogenase and p-hydroxyphenylpyruvate dioxygenase |
WO2004058934A3 (en) * | 2002-12-23 | 2004-09-02 | Sungene Gmbh & Co Kgaa | Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
WO2004058934A2 (en) * | 2002-12-23 | 2004-07-15 | Sungene Gmbh & Co. Kgaa | Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content |
Also Published As
Publication number | Publication date |
---|---|
WO2000008169A8 (en) | 2000-05-04 |
AU757440B2 (en) | 2003-02-20 |
CA2339519A1 (en) | 2000-02-17 |
AU5415799A (en) | 2000-02-28 |
JP2002525034A (en) | 2002-08-13 |
EP1102852A1 (en) | 2001-05-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1102852A1 (en) | Dna sequence coding for a 1-deoxy-d-xylulose-5-phosphate synthase and the overproduction thereof in plants | |
WO1999004021A1 (en) | Dna sequence coding for a hydroxyphenylpyruvate dioxygenase and overproduction thereof in plants | |
EP1294913B1 (en) | Changing the fine chemical content in organisms by genetically modifying the shikimate pathway | |
DE60129011T2 (en) | NUCLEIC ACID SEQUENCES FOR PROTEINS INVOLVED IN TOCOPHEROL BIOSYNTHESIS | |
EP1194577A1 (en) | Identification and overexpression of a dna sequence coding for 2-methyl-6-phytylhydroquinone-methyltransferase in plants | |
EP1299413A2 (en) | Homogentisate phytyl transferase | |
EP1180149A2 (en) | Overexpression of a dna sequence coding for a 1-desoxy-d-xylulose-5-phosphate reductoisomerase in plants | |
DE10046462A1 (en) | Improved procedures for vitamin E biosynthesis | |
KR20010105373A (en) | Method for Improving the Agronomic and Nutritional Value of Plants | |
DE10111676A1 (en) | Increasing vitamin E content in organisms by increasing tyrosine aminotransferase activity | |
DE19752647C1 (en) | Reduction of the chlorophyll content in oil plant seeds | |
DE19835219A1 (en) | Use of 1-deoxy-D-xylulose-5-phosphate synthase DNA to produce plants with increased tocopherol, vitamin K, chlorophyll and/or carotenoid content | |
DE19937957A1 (en) | Homogenate dioxygenase | |
WO2000044911A1 (en) | Overexpression of a dna sequence coding for a transketolase in plants | |
DE19845231A1 (en) | Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content | |
WO1999022011A1 (en) | Reduction of chlorophyll content in oil plant seeds | |
DE19845216A1 (en) | Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content | |
DE19845224A1 (en) | Use of DNA encoding 1-deoxy-D-xylulose-5-phosphate synthase to produce plants with increased tocopherol, vitamin K, chlorophyll and carotenoid content | |
Abbasi | Functional analysis of tocopherol biosynthesis in plants | |
WO2004058934A2 (en) | Method for producing transgenic plants having an elevated vitamin e content by modifying the serine-acetyltransferase content | |
DE10064454A1 (en) | Preparing fine chemicals, particularly Vitamins E and K, useful as antioxidants e.g. in foods or medicine, by growing organisms with altered shikimate biosynthesis pathway | |
EP1198578A2 (en) | PLANT S-ADENOSYLMETHIONIN:Mg-PROTOPORPHYRIN-IX-O-METHYLTRANSFERASE, PLANTS WITH VARIABLE CHLOROPHYLL CONTENTS AND/OR HERBICIDE TOLERANCE, AND METHOD FOR THE PRODUCTION THEREOF | |
DE10030647A1 (en) | Preparing fine chemicals, particularly Vitamins E and K, useful as antioxidants e.g. in foods or medicine, by growing organisms with altered shikimate biosynthesis pathway | |
DE19632121A1 (en) | Transgenic plant cells |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AU BG BR BY CA CN CZ GE HR HU ID IL IN JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: C1 Designated state(s): AL AU BG BR BY CA CN CZ GE HR HU ID IL IN JP KR KZ LT LV MK MX NO NZ PL RO RU SG SI SK TR UA US ZA |
|
AL | Designated countries for regional patents |
Kind code of ref document: C1 Designated state(s): AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
CFP | Corrected version of a pamphlet front page | ||
CR1 | Correction of entry in section i | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999940083 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2339519 Country of ref document: CA Ref country code: CA Ref document number: 2339519 Kind code of ref document: A Format of ref document f/p: F |
|
WWE | Wipo information: entry into national phase |
Ref document number: 54157/99 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1999940083 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 09762045 Country of ref document: US |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWG | Wipo information: grant in national office |
Ref document number: 54157/99 Country of ref document: AU |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1999940083 Country of ref document: EP |